Compositions and methods for modulating expression of gene products

ABSTRACT

Compositions and methods for modulating expression of gene products are provided. Compositions comprise suppression cassettes that comprise a convergent promoter pair operably linked to a silencing element that, upon expression, is capable of decreasing the expression of one or more target polynucleotides of interest. Compositions of the invention also include transformed plants, plant cells, plant tissues, and plant seeds. Methods of transformation and regeneration of plants comprising the novel constructs are provided. The methods find use in regulating gene expression, particularly genes associated with agronomic traits of interest. Further provided are promoter sequences, cells, plants, and vectors comprising these promoter sequences and methods of their use.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation application of U.S. application Ser.No. 11/513,330 filed on Aug. 29, 2006 which claims the benefit of U.S.Provisional Application No. 60/712,354, filed on Aug. 30, 2005, both ofwhich are herein incorporated by reference in their entirety.

FIELD OF THE INVENTION

The present invention is drawn to the field of genetics and molecularbiology. More particularly, the compositions and methods are directed tomodulation of gene function.

BACKGROUND OF THE INVENTION

RNA interference (RNAi) is a phenomenon in which small double-strandedRNA molecules induce sequence-specific degradation of homologoussingle-stranded RNA. RNAi has been used as a tool to degrade mRNA incells to shut down the effect of specific genes in many cell-types. Inthis approach to control gene expression, double-stranded RNAs that arecomplimentary to known mRNA's are introduced into a cell to specificallytarget and destroy that particular mRNA. Once double stranded RNA(dsRNA) enters the cell, it is cleaved by a ribonuclease enzyme, dicer,into double stranded small interfering RNAs (siRNAs). The siRNAs becomeintegrated into a multi-subunit protein complex which guides the siRNAsto the target RNA sequence.

In plants, RNAi can be induced through microinjection of longdouble-stranded RNA or by introduction of DNA constructs that may betranscribed into such double-stranded RNA molecules. The double-strandedRNA is cleaved into RNA fragments of about 19 to 23 nucleotides calledinterfering RNAs (siRNAs). siRNAs are incorporated into a ribonucleaseenzyme complex known as the RNA-induced silencing complex (RISC). Theantisense strand of siRNA within the RISC pathway serves as a guide forsequence-specific degradation of homologous messenger RNAs.

The ability of transfected synthetic small interfering RNAs to suppressthe expression of specific transcripts has proven to be a useful tool tostudy gene function. Recently short hairpin RNAs (shRNAs) have beenshown to result in gene silencing as effectively as short dsRNAs.Several DNA-based vectors have been developed that direct transcriptionof small hairpin RNAs (shRNAs). These RNAs are processed into functionalsiRNAs by cellular enzymes. RNAi vectors for the expression of shRNAsare available. These vectors typically use RNA polymerase III (Pol III)to express short hairpin RNAs. These transcripts adopt stem-loopstructures that are processed into siRNAs by the RNAi machinery.

Other vectors have been developed that drive expression of both thesense and antisense strands of a DNA construct separately. Thetranscripts hybridize in vivo to make the siRNA. In efforts to inducelong-term gene silencing, expression vectors that continually expresssiRNAs in stably transfected cells have been used.

Presently, silencing genes in more than one tissue requires the use oftwo separate expression cassettes. This approach takes up valuable spacein a molecular stack, increasing the regulatory burden for sequence andexpression confirmation, as well as, the potential for undesirablerearrangements and deletions. Currently available promoters,particularly tissue-preferred promoters, may not cover the entiretemporal range of expression need to achieve the trait goals. Methodsand compositions are needed that avoid these complications and allow fordifferential expression or the increased time-frame of expression of asilencing element without an increase in the size of the expressioncassette.

BRIEF SUMMARY OF THE INVENTION

Compositions and methods are provided for modulating the expression andfunction of target polynucleotides of interest and the polypeptides theyencode in an organism. Compositions of the invention include suppressioncassettes comprising a silencing element, having homology to at leastone target polynucleotide of interest. The silencing element istranscribed as a hairpin RNA and is flanked and operably linked toconvergent promoters such that each promoter is capable of drivingexpression of the silencing element in opposite directions.

A variety of promoters may be used in the suppression cassettes. Whileany promoter may be used in the suppression cassette, generally thecassette is designed such that the promoters have a different expressionprofile. That is, the promoters drive expression in different tissues orat different developmental stages of an organism. Thus, by the choice ofpromoters, temporal and tissue expression of the transcripts can becontrolled. In the same manner, to more effectively control a disease,the promoters may be chosen to be expressed at different stages of adisease or pathogen infection.

Compositions of the invention also include transformed organisms such asplants, animals (mammals, humans, etc), bacteria, and fungi comprisingthe suppression cassettes of the invention as well as transformed cellsof such organisms. Compositions of the invention also include plantcells, plant tissues, plants, and plant seeds comprising the suppressioncassettes of the invention stably incorporated in their genome.

Methods of the invention comprise the use of these suppression cassettesto provide for expression of inhibitory RNA molecules, includingdouble-stranded RNA, hairpin RNA, intron-containing hairpin RNA,stem-loop RNA, and the like, that have been designed to inhibitexpression of at least one polynucleotide of interest at different timesor in different tissues. Also included are methods of transformation andregeneration of plants comprising the recombinant constructs of theinvention.

The compositions and methods of the invention are useful for decreasingexpression and function of gene products of interest, thereby alteringthe phenotype of an organism or cell of interest. In some embodiments,the construct can be used to improve characteristics of commerciallyimportant plants and plant parts. Thus, the compositions and methods canbe used to improve the yield and quality of desirable plant productsthereby improving agronomic efficiency. In other embodiments, genes thatare indicative of disease states in a mammal, such as cancer genes, maybe targeted.

Further provided are compositions and methods for regulating expressionof a heterologous nucleotide sequence of interest in a plant or plantcell. Compositions comprise novel polynucleotides for promoters thatinitiate transcription. Embodiments of the invention comprise thepolynucleotide set forth in SEQ ID NO:3 or a complement thereof; anucleotide sequence comprising at least 20 contiguous nucleotides of SEQID NO:3, wherein said sequence initiates transcription in a plant cell;and, a nucleotide sequence comprising a sequence having at least 85%sequence identity to the sequence set forth in SEQ ID NO:3, wherein saidsequence initiates transcription in the plant cell.

A method for expressing a heterologous nucleotide sequence in a plant orplant cell is provided. The method comprises introducing into a plant ora plant cell an expression cassette comprising a heterologous nucleotidesequence interest operably linked to one of the promoters of the presentinvention. In this manner, the promoter sequences are useful forcontrolling the expression of the operably linked heterologousnucleotide sequence. In specific methods, the heterologous nucleotidesequence of interest is expressed in an embryo-preferred manner.

Further provided is a method for expressing a nucleotide sequence ofinterest in an embryo-preferred manner in a plant. The method comprisesintroducing into a plant cell an expression cassette comprising apromoter of the invention operably linked to a heterologous nucleotidesequence of interest.

Expression of the nucleotide sequence of interest can provide formodification of the phenotype of the plant. Such modification includesmodulating the production of an endogenous product, as to amount,relative distribution, or the like, or production of an exogenousexpression product to provide for a novel function or product in theplant. In specific methods and compositions, the heterologous nucleotidesequence of interest comprises a gene product that confers herbicideresistance, pathogen resistance, insect resistance, and/or alteredtolerance to salt, cold, or drought. Expression cassettes comprising thepromoter sequences of the invention operably linked to a heterologousnucleotide sequence of interest are provided. Additionally provided aretransformed plant cells, plant tissues, seeds, and plants.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 depicts a plasmid (Plasmid A) comprising a suppression cassettehaving a silencing element comprising an RGP1 inhibitory sequence (SEQID NO:2) under dual control by a gamma-zein promoter and an oleosinpromoter. The RGP1 inhibitory sequence comprises a truncated RGP1 region(TR1) from the 5′ end of the RGP1 coding sequence (U.S. Pat. No.6,194,638) and a second truncated RGP1 region (TR2) also from the 5′ endof the RGP1 coding sequence but which is ligated into the silencingelement of the suppression cassette such that the second fragment is inreverse orientation relative to the first RGP1 fragment.

FIG. 2 depicts a vir integrated plasmid (Plasmid B) comprising thesuppression cassette shown in FIG. 1.

FIG. 3 depicts a total protein stain and Western blot of wild-type (WT)maize mature endosperm and transgenic (T) maize mature endospermscomprising the RGP1 suppression construct. Mature kernels were obtainedfrom the same transgenic event.

FIG. 4 depicts the total hemicellulose concentration (as a percent ofcontrol) for transgenic kernels comprising the RGP1 suppressionconstruct. Those transgenic events yielding at least 3 wild-type and atleast 3 transgenic kernels were selected for hemicellulose analysis.Twenty-two out of 36 transgenic events met these criteria. Kernels fromthe same ear were pooled into transgenic or wild-type for this analysis.

FIG. 5 depicts the total arabinose plus xylose concentration (as apercent of control) for transgenic kernels comprising the RGP-1suppression construct. Analyses were as described for FIG. 4.

FIG. 6 depicts the total arabinose concentration (as a percent ofcontrol) for transgenic kernels comprising the RGP-1 suppressionconstruct. Analyses were as described for FIG. 4.

FIG. 7 depicts the total xylose concentration (as a percent of control)for transgenic kernels comprising the RGP-1 suppression construct.Analyses were as described for FIG. 4.

FIG. 8 depicts the ratio of arabinose to xylose for transgenic kernelscomprising the RGP-1 suppression construct as compared to thecorresponding ratio for wild-type kernels. Analyses were as describedfor FIG. 4.

FIG. 9 depicts the total hemicellulose concentration (as a percent ofcontrol) for transgenic kernels comprising the RGP-1 suppressionconstruct. Mature endosperm of 18 kernels from each of 13 transgenicevents were rescreened for hemicellulose and individual sugar content.Kernels from the same ear were pooled into transgenic or wild-type forthis analysis.

FIG. 10 depicts the arabinose (A) and xylose (B) concentrations (as apercent of control) for transgenic kernels comprising the RGP-1suppression construct. Analyses were as described for FIG. 9.

FIG. 11 depicts the total arabinose plus xylose concentration (as apercent of control) for transgenic kernels comprising the RGP-1suppression construct. Analyses were as described for FIG. 9.

FIG. 12 depicts the ratio of arabinose to xylose for transgenic kernelscomprising the RGP-1 suppression construct as compared to thecorresponding ratio for wild-type kernels. Analyses were as describedfor FIG. 9.

FIG. 13 depicts a chromatogram of sugar concentrations in transgenickernels as compared to wild-type kernels for transgenic kernelscomprising either an RGP-1 suppression construct (top) or a UDP-glucosesuppression construct.

FIG. 14 shows LYNX data which demonstrates that the Glb2 promoterdirects transcription between 20-24 DAP and is off by 35 DAP. Glb2 hasvirtually no signal from the aleurone which makes it very unique in theclass of embryo promoters.

DETAILED DESCRIPTION OF THE INVENTION

I. Suppression Cassettes and Methods of Use

The present invention is drawn to compositions and methods formodulating expression of gene products in organisms such as plants,animals, fungi, and bacteria. Compositions of the invention comprise arecombinant construct referred to herein as a suppression cassette. Thesuppression cassette comprises a silencing element flanked at both endsby promoters capable of driving expression of the silencing element.That is, each promoter is “operably linked” to the silencing element.The two promoters flanking the silencing element are capable ofcontrolling gene expression in different tissues or types of cells aswell as in different stages of development depending on the choice ofpromoters.

By “silencing element” is intended a polynucleotide which when expressedin a host cell, is capable of reducing or eliminating the level of atarget polynucleotide or the polypeptide encoded thereby. The silencingelement employed can reduce or eliminate the level of the targetsequence by influencing the level of the target RNA transcript or,alternatively, by influencing translation and thereby affecting thelevel of the encoded polypeptide. Methods to assay for functionalsilencing elements that are capable of reducing or eliminating the levelof a sequence of interest are disclosed elsewhere herein. A singlesuppression cassette employed in the invention can harbor one or moresilencing elements which, as discussed in further detail below, aredesigned to decrease the level of expression of the same or differenttarget polynucleotides. The RNA transcripts of the silencing element,after self-pairing, comprise regions of double-stranded RNA and arereferred to herein interchangeably as “inhibitory RNA transcripts” or“inhibitory RNA molecules.” These inhibitory RNA transcripts candecrease the level of one or more target polynucleotide of interest.

Methods for designing silencing elements that express a hairpinstructure and its use in RNA interference to decrease or silence theexpression of genes are described, for example, in Chuang and Meyerowitz(2000) Proc. Natl. Acad. Sci. USA 97:4985-90; Stoutjesdijk et al. (2002)Plant Physiology 129:1723-31; Waterhouse and Helliwell (2003) Nat. Rev.Gen. 4:29-38; Pandolfini et al. BMC Biotechnology 3:7, and U.S. PatentApplication Publication No. 20030175965, each of which is hereinincorporated by reference. For hairpin RNA (hpRNA) interference, thesilencing element traditionally is designed to express an RNA transcriptthat pairs with itself to form a hairpin structure that comprises asingle-stranded loop region and a base-paired stem. hpRNA molecules arehighly efficient at inhibiting the expression of endogenous genes, andthe RNA interference they induce is inherited by subsequent generationsof plants. A transient assay for the efficiency of hpRNA constructs tosilence gene expression in vivo has been described by Panstruga et al.(2003) Mol. Biol. Rep. 30:135-40, herein incorporated by reference.

In specific embodiments, the silencing element employed in the methodsand compositions of the invention comprises in the following order, afirst segment, a second segment, and a third segment, where the firstand the third segment share sufficient complementarity to allow thetranscribed RNA to form a double-stranded stem-loop structure. “Stem andloop structure” and “stem-loop structure” are used synonymously hereinand are intended to mean a single RNA polynucleotide molecule wherein aregion closer to the 5′ end of the molecule pairs with aself-complementary region closer to the 3′ end of the molecule to form adouble-stranded RNA region (known as the stem or “arms” of thestructure) while an intervening region between the 5′ and 3′self-complementary regions remains unpaired (known as the “loop”). AnRNA hairpin structure is an example of a stem-loop structure capable ofcausing RNA interference.

The “second segment” of the hairpin comprises a “loop” or a “loopregion.” These terms are used synonymously herein and are to beconstrued broadly to comprise any nucleotide sequence that confersenough flexibility to allow self-pairing to occur between complementaryregions of a polynucleotide (i.e., segments 1 and 2 which form the stemof the hairpin). For example, in some embodiments, the loop region maybe substantially single stranded and act as a spacer between theself-complementary regions of the hairpin stem-loop. In someembodiments, the loop region can comprise a random or nonsensenucleotide sequence and thus not share sequence identity to a targetpolynucleotide. In other embodiments, the loop region comprises a senseor an antisense RNA sequence or fragment thereof that shares identity toa target polynucleotide. See, for example, International PatentPublication No. WO 02/00904, herein incorporated by reference.

In some embodiments, the loop region can comprise one or more spliceableintrons. In such constructs (referred to as ihpRNA), the inhibitory RNAtranscripts have the same general structure as the hpRNA, but the RNAmolecule additionally comprises an intron that is capable of beingspliced in the cell in which the ihpRNA is expressed. Forintron-containing hairpin RNA (ihpRNA), the inhibitory polynucleotideshave the same general structure as for hpRNA, but the RNA moleculeadditionally comprises an intron that is capable of being spliced in thecell in which the ihpRNA is expressed. See, for example, Smith et al.(2000) Nature 407:319-320; Wesley et al. (2001) The Plant Journal27:581-590; Wang and Waterhouse (2001) Current Opinion in Plant Biology5:146-150; Waterhouse and Helliwell (2003) Nat. Rev. Gen. 4:29-38;Helliwell and Waterhouse (2003) Methods 30:289-95, and U.S. PatentPublication No. 20030180945, each of which is herein incorporated byreference. Any intron that is spliced may be used according to theinvention. Non-limiting examples of introns that may be used include theorthophosphate dikinase 2 intron 2 (pdk2 intron) described in U.S.Patent Application Publication No. 20030180945, the catalase intron fromcastor bean (GenBank Accession No. AF274974), the delta-12 desaturase(FAD2) intron from cotton (GenBank Accession No. AF331163), the delta-12desaturase (FAD2) intron from Arabidopsis (GenBank Accession No.AC069473), the ubiquitin intron from maize (GenBank Accession No.S94464), an actin intron from rice, the maize ADHI intron1, the potatoST-LS1 intron2.

When the loop region (i.e., the second segment) does not contain anintron, it can be optimized to be as short as possible while stillproviding enough intramolecular flexibility to allow the formation ofthe base-paired stem region. Accordingly, the loop sequence is generallyless than 1000 nucleotides, less than 900 nucleotides, less than 800nucleotides, less than 700 nucleotides, less than 600 nucleotides, lessthan 500 nucleotides, less than 400 nucleotides, less than 300nucleotides, less than 200 nucleotides, less than 100 nucleotides, lessthan 50 nucleotides, less than 25 nucleotides, less than 20 nucleotides,less than 15 nucleotides or about 10 nucleotides or less.

The “first” and the “third” segment of the hairpin RNA molecule comprisethe base-paired stem of the hairpin structure. The first and the thirdsegments are inverted repeats of one another and share sufficientcomplementarity to allow the formation of the base-paired stem region.In specific embodiments, the first and the third segments are fullycomplementary to the one another. Alternatively, the first and the thirdsegment may be partially complementary to each other so long as they arecapable of hybridizing to one another to form a base-paired stem region.The amount of complementarity between the first and the third segmentcan be calculated as a percentage of the entire segment. Thus, the firstand the third segment of the hairpin RNA generally share at least 50%,60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, upto and including 100% complementarity.

The first and the third segment are at least about 1000, 500, 400, 300,200, 100, 50, 40, 30, 25, 20, 15 or 10 nucleotides in length. Inspecific embodiments, the length of the first and/or the third segmentis about 10-100 nucleotides, about 10 to about 75 nucleotides, about 10to about 50 nucleotides, about 10 to about 40 nucleotides, about 10 toabout 35 nucleotides, about 10 to about 30 nucleotides, about 10 toabout 25 nucleotides, about 10 to about 20 nucleotides. In otherembodiments, the length of the first and/or the third segment comprisesat least 10-20 nucleotides, 20-35 nucleotides, 30-45 nucleotides, 40-50nucleotides, 50-100 nucleotides, or 100-300 nucleotides. See, forexample, International Publication No. WO 0200904. In specificembodiments, the first and the third segment comprises at least 20nucleotides having at least 85% complementary to the first segment. Instill other embodiments, the first and the third segments which form thestem-loop structure of the hairpin comprises 3′ or 5′ overhang regionshaving unpaired nucleotide residues.

In specific embodiments, the sequences used in the first, the second,and/or the third segments comprise domains that are designed to havesufficient sequence identity to a target polynucleotide of interest andthereby have the ability to decrease the level of expression of thetarget polynucleotide. The specificity of the inhibitory RNA transcriptsis therefore generally conferred by these domains of the silencingelement. Thus, in some embodiments of the invention, the first, secondand/or third segment of the silencing element comprise a domain havingat least 10, at least 15, at least 19, at least 20, at least 21, atleast 22, at least 23, at least 24, at least 25, at least 30, at least40, at least 50, at least 100, at least 200, at least 300, at least 500,at least 1000, or more than 1000 nucleotides that share sufficientsequence identity to the target polynucleotide to allow for a decreasein expression levels of the target polynucleotide when expressed in anappropriate cell. In other embodiments, the domain is between about 15to 50 nucleotides, about 20-35 nucleotides, about 25-50 nucleotides,about 20 to 75 nucleotides, about 40-90 nucleotides about 15-100nucleotides. In specific embodiments, the domain of the first, thesecond, and/or the third segment has 100% sequence identity to thetarget polynucleotide. In other embodiments, the domain of the first,the second and/or the third segment having homology to the targetpolypeptide have at least 50%, 60%, 70%, 80%, 85%, 90%, 91%, 92%, 93%,94%, 95%, 96%, 97%, 98%, 99%, or greater sequence identity to a regionof the target polynucleotide. The sequence identity of the domains ofthe first, the second and/or the third segments to the targetpolynucleotide need only be sufficient to decrease expression of thetarget polynucleotide of interest.

The amount of complementarity shared between the first, second, and/orthird segment and the target polynucleotide or the amount ofcomplementarity shared between the first segment and the third segment(i.e., the stem of the hairpin structure) may vary depending on theorganism in which gene expression is to be controlled. Some organisms orcell types may require exact pairing or 100% identity, while otherorganisms or cell types may tolerate some mismatching. In some cells,for example, a single nucleotide mismatch in the targeting sequenceabrogates the ability to suppress gene expression. In these cells, thesuppression cassettes of the invention can be used to target thesuppression of mutant genes, for example, oncogenes whose transcriptscomprise point mutations and therefore they can be specifically targetedusing the methods and compositions of the invention without altering theexpression of the remaining wild-type allele.

Any region of the target polynucleotide can be used to design the domainof the silencing element that shares sufficient sequence identity toallow expression of the hairpin transcript to decrease the level of thetarget polynucleotide. For instance, the domain can be designed to sharesequence identity to the 5′ untranslated region of the targetpolynucleotide(s), the 3′ untranslated region of the targetpolynucleotide(s), exonic regions of the target polynucleotide(s),intronic regions of the target polynucleotide(s), and any combinationthereof. In some instances to optimize the siRNA sequences employed inthe hairpin, the synthetic oligodeoxyribonucleotide/RNAse H method canbe used to determine sites on the target mRNA that are in a conformationthat is susceptible to RNA silencing. See, for example, Vickers et al.(2003) J. Biol. Chem 278:7108-7118 and Yang et al. (2002) Proc. Natl.Acad. Sci. USA 99:9442-9447, herein incorporated by reference. Thesestudies indicate that there is a significant correlation between theRNase-H-sensitive sites and sites that promote efficient siRNA-directedmRNA degradation.

It is recognized that multiple members of a gene family can be targetedusing this method. For example, a silencing element can be designed,based on sequence identity shared among various members of a genefamily, and thereby decrease the expression of multiple relatedpolynucleotides. Alignment of the family members can be used to designsuch a silencing element.

It is further recognized that multiple unrelated target polynucleotidescan also be targeted. For example, where the purpose is to decrease thelevel of expression of more than one target polynucleotide, regions ofDNA whose sequence corresponds to that present in the different targetpolynucleotides can be combined into the first, second, and/or thirdsegment of the silencing element. In this manner, the suppressioncassette is designed to express a single fusion RNA transcript havingspecificity for multiple target polynucleotides.

In some embodiments, the second segment (i.e., the loop region) maycomprise all or part of a sequence corresponding to a targetpolynucleotide of interest. While the stem structure (i.e., the firstand third segment) of the hairpin transcript will, in most instances, bedesigned to target a gene product, it is contemplated that thebase-paired stem structure of the inhibitory RNA transcript may beformed by the hybridization of a first segment and a second segment,neither of which correspond to an endogenous sequence found in theorganism of interest.

The following terms are used to describe the sequence relationshipsbetween two or more polynucleotides: (a) “reference sequence”, (b)“comparison window”, (c) “sequence identity”, and, (d) “percentage ofsequence identity”.

(a) As used herein, “reference sequence” is a defined sequence used as abasis for sequence comparison. A reference sequence may be a subset orthe entirety of a specified sequence; for example, as a segment of afull-length cDNA or gene sequence, or the complete cDNA or genesequence.

(b) As used herein, “comparison window” makes reference to a contiguousand specified segment of a polynucleotide sequence, wherein thepolynucleotide sequence in the comparison window may comprise additionsor deletions (i.e., gaps) compared to the reference sequence (which doesnot comprise additions or deletions) for optimal alignment of the twopolynucleotides. Generally, the comparison window is at least 20contiguous nucleotides in length, and optionally can be 30, 40, 50, 100,or longer. Those of skill in the art understand that to avoid a highsimilarity to a reference sequence due to inclusion of gaps in thepolynucleotide sequence a gap penalty is typically introduced and issubtracted from the number of matches.

Methods of alignment of sequences for comparison are well known in theart. Thus, the determination of percent sequence identity between anytwo sequences can be accomplished using a mathematical algorithm.Non-limiting examples of such mathematical algorithms are the algorithmof Myers and Miller (1988) Comput. Appl. Biosci. 4:11-17; the localalignment algorithm of Smith et al. (1981) Adv. Appl. Math. 2:482; theglobal alignment algorithm of Needleman and Wunsch (1970) J. Mol. Biol.48:443-453; the search-for-local alignment method of Pearson and Lipman(1988) Proc. Natl. Acad. Sci. USA 85:2444-2448; the algorithm of Karlinand Altschul (1990) Proc. Natl. Acad. Sci. USA 872264, modified as inKarlin and Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873-5877.

Computer implementations of these mathematical algorithms can beutilized for comparison of sequences to determine sequence identity.Such implementations include, but are not limited to: CLUSTAL in thePC/Gene program (available from Intelligenetics, Mountain View, Calif.);the ALIGN program (Version 2.0) and GAP, BESTFIT, BLAST, FASTA, andTFASTA in the GCG Wisconsin Genetics Software Package, Version 10(available from Accelrys Inc., 9685 Scranton Road, San Diego, Calif.,USA). Alignments using these programs can be performed using the defaultparameters. The CLUSTAL program is well described by Higgins et al.(1988) Gene 73:237-244 (1988); Higgins et al. (1989) Comput. Appl.Biosci. 5:151-153; Corpet et al. (1988) Nucleic Acids Res. 16:10881-90;Huang et al. (1992) CABIOS 8:155-65; and Pearson et al. (1994) MethodsMol. Biol. 24:307-331. The ALIGN program is based on the algorithm ofMyers and Miller (1988) supra. A PAM120 weight residue table, a gaplength penalty of 12, and a gap penalty of 4 can be used with the ALIGNprogram when comparing amino acid sequences. The BLAST programs ofAltschul et al. (1990) J. Mol. Biol. 215:403 are based on the algorithmof Karlin and Altschul (1990) supra. BLAST nucleotide searches can beperformed with the BLASTN program, score=100, wordlength=12, to obtainnucleotide sequences homologous to a nucleotide sequence encoding aprotein of the invention. To obtain gapped alignments for comparisonpurposes, Gapped BLAST (in BLAST 2.0) can be utilized as described inAltschul et al. (1997) Nucleic Acids Res. 25:3389. Alternatively,PSI-BLAST (in BLAST 2.0) can be used to perform an iterated search thatdetects distant relationships between molecules. See Altschul et al.(1997) supra. When utilizing BLAST, Gapped BLAST, PSI-BLAST, the defaultparameters of the respective programs (e.g., BLASTN for nucleotidesequences, BLASTX for proteins) can be used. Alignment may also beperformed manually by inspection.

Unless otherwise stated, sequence identity/similarity values providedherein refer to the value obtained using GAP Version 10 using thefollowing parameters: % identity and % similarity for a nucleotidesequence using GAP Weight of 50 and Length Weight of 3, and thenwsgapdna.cmp scoring matrix; % identity and % similarity for an aminoacid sequence using GAP Weight of 8 and Length Weight of 2, and theBLOSUM62 scoring matrix; or any equivalent program thereof. “Equivalentprogram” is intended to mean any sequence comparison program that, forany two sequences in question, generates an alignment having identicalnucleotide or amino acid residue matches and an identical percentsequence identity when compared to the corresponding alignment generatedby GAP Version 10.

GAP uses the algorithm of Needleman and Wunsch (1970) J. Mol. Biol.48:443-453, to find the alignment of two complete sequences thatmaximizes the number of matches and minimizes the number of gaps. GAPconsiders all possible alignments and gap positions and creates thealignment with the largest number of matched bases and the fewest gaps.It allows for the provision of a gap creation penalty and a gapextension penalty in units of matched bases. GAP must make a profit ofgap creation penalty number of matches for each gap it inserts. If a gapextension penalty greater than zero is chosen, GAP must, in addition,make a profit for each gap inserted of the length of the gap times thegap extension penalty. Default gap creation penalty values and gapextension penalty values in Version 10 of the GCG Wisconsin GeneticsSoftware Package for protein sequences are 8 and 2, respectively. Fornucleotide sequences the default gap creation penalty is 50 while thedefault gap extension penalty is 3. The gap creation and gap extensionpenalties can be expressed as an integer selected from the group ofintegers consisting of from 0 to 200. Thus, for example, the gapcreation and gap extension penalties can be 0, 1, 2, 3, 4, 5, 6, 7, 8,9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, or greater.

GAP presents one member of the family of best alignments. There may bemany members of this family, but no other member has a better quality.GAP displays four figures of merit for alignments: Quality, Ratio,Identity, and Similarity. The Quality is the metric maximized in orderto align the sequences. Ratio is the quality divided by the number ofbases in the shorter segment. Percent Identity is the percent of thesymbols that actually match. Percent Similarity is the percent of thesymbols that are similar. Symbols that are across from gaps are ignored.A similarity is scored when the scoring matrix value for a pair ofsymbols is greater than or equal to 0.50, the similarity threshold. Thescoring matrix used in Version 10 of the GCG Wisconsin Genetics SoftwarePackage is BLOSUM62 (see Henikoff and Henikoff (1989) Proc. Natl. Acad.Sci. USA 89:10915).

(c) As used herein, “sequence identity” or “identity” in the context oftwo polynucleotides makes reference to the residues in the two sequencesthat are the same when aligned for maximum correspondence over aspecified comparison window. A “complement sequence” in the context oftwo oppositely orientated polynucleotides make reference to thenucleotide residues which when aligned interact to form adouble-stranded structure (i.e., the complementary sequence to5′-G-T-A-C-3′ is 3′-C-A-T-G-5′).

(d) As used herein, “percentage of sequence identity” means the valuedetermined by comparing two optimally aligned sequences over acomparison window, wherein the portion of the polynucleotide sequence inthe comparison window may comprise additions or deletions (i.e., gaps)as compared to the reference sequence (which does not comprise additionsor deletions) for optimal alignment of the two sequences. The percentageis calculated by determining the number of positions at which theidentical nucleic acid base occurs in both sequences to yield the numberof matched positions, dividing the number of matched positions by thetotal number of positions in the window of comparison, and multiplyingthe result by 100 to yield the percentage of sequence identity. As usedherein “percent complementarity” means the value determined by comparingthe complementarity of two oppositely orientated polynucleotides. Thepercentage is calculated by determining the number of positions at whichthe complement nucleic acid base occurs in both sequences to yield thenumber of complement positions, dividing the number of complementpositions by the total number of positions in the window of comparison,and multiplying the result by 100 to yield the percentage of sequencecomplementarity.

The suppression cassettes disclosed herein comprise two convergentpromoters that drive transcription of an operably linked silencingelement. “Convergent promoters” refers to promoters that are oriented oneither terminus of the operably linked silencing element such that eachpromoter drives transcription of the silencing element in oppositedirections, yielding two transcripts. In specific embodiments, thepromoters are chosen to provide differential expression of therespective transcripts.

The two convergent promoters within the suppression cassette are chosento provide for different temporal and/or spatial patterns (i.e.,different cell types and/or tissues) of expression of the hairpin RNAtranscripts encoded by the silencing element. Likewise they can bechosen to be expressed in different cell types or tissues of anorganism. Any combination of promoters can be used to direct thetemporal and/or spatial expression of the operably linked silencingelement in a host organism of interest as long as the promoters arecapable of initiating transcription in the host cell. “Differentialexpression profiles” refers to two promoters capable of drivingtranscription of the same operably linked silencing element but havingdifferent time frames during which they operate to drive expression,such as during different developmental stages, growth stages,environmental conditions, etc., and/or to two promoters capable ofdriving transcription of the same operably linked silencing element butwhich provide for different spatial expression patterns, such asexpression in different tissues, organs, cells, etc., or combinationsthereof. The term “differential expression profile” is to be construedbroadly, and thus the difference in expression profiles can range fromalmost entirely overlapping expression to mutually exclusive expression,as long as some difference in the expression profiles exists.

Where the organism is a plant, a differential expression profile can beachieved by selecting promoters that are under developmental control,such as promoters that initiate transcription preferentially in certaintissues, such as leaves, roots, fruit, seeds, or flowers. Alternatively,one or both of the convergent promoters can be an inducible promoter,for example, a chemical-inducible promoter wherein expression within theplant or part thereof is induced in response to exposure of the plant orpart thereof to the chemical. In other embodiments, one or both of theconvergent promoters can be induced by an environmental stimuli such as,but not limited to, drought, temperature, salinity, light, or disease.Of particular interest are tissue-preferred promoters that provide forspatially different expression profiles and can further provide fortemporally different expression profiles.

Inducible promoters are known in the art and include, but are notlimited to, that from the ACEI system, which responds to copper (Mett etal. (1993) Proc. Natl. Acad. Sci. USA 90:4567-4571 (1993)); the maizeIn2-2 promoter, which is activated by benzenesulfonamide herbicidesafeners (Hershey et al. (1991) Mol. Gen. Genet. 227:229-237 and Gatz etal. (1994) Mol. Gen. Genetics 243:32-38); the maize GST promoter, whichis activated by hydrophobic electrophilic compounds that are used aspre-emergent herbicides; the tobacco PR-1a promoter, which is activatedby salicylic acid; and Tet repressor from Tn10 (Gatz et al. 1991) Mol.Gen. Genet. 227:229-237). A particularly preferred inducible promoter isa promoter that responds to an inducing agent to which plants do notnormally respond. Exemplary promoters are steroid-responsive promoters(see, for example, the glucocorticoid-inducible promoter in Schena etal. (1991) Proc. Natl. Acad. Sci. USA 88:10421-10425 and McNellis et al.(1998) Plant J. 14(2):247-257) and tetracycline-inducible promoters(see, for example, Gatz et al. (1991) Mol. Gen. Genet. 227:229-237, andU.S. Pat. Nos. 5,814,618 and 5,789,156), herein incorporated byreference.

Tissue-preferred promoters can be utilized to drive expression ofinhibitory RNA transcripts within a particular plant tissue.Tissue-preferred promoters can be utilized to target enhanced expressionwithin a particular plant tissue. Tissue-preferred promoters includeYamamoto et al. (1997) Plant J. 12(2):255-265; Kawamata et al. (1997)Plant Cell Physiol. 38(7):792-803; Hansen et al. (1997) Mol. Gen Genet.254(3):337-343; Russell et al. (1997) Transgenic Res. 6(2):157-168;Rinehart et al. (1996) Plant Physiol. 112(3):1331-1341; Van Camp et al.(1996) Plant Physiol. 112(2):525-535; Canevascini et al. (1996) PlantPhysiol. 112(2):513-524; Yamamoto et al. (1994) Plant Cell Physiol.35(5):773-778; Lam (1994) Results Probl. Cell Differ. 20:181-196; Orozcoet al. (1993) Plant Mol Biol. 23(6):1129-1138; Matsuoka et al. (1993)Proc Natl. Acad. Sci. USA 90(20):9586-9590; and Guevara-Garcia et al.(1993) Plant J. 4(3):495-505. Such promoters can be modified, ifnecessary, for weak expression.

Leaf-preferred promoters are known in the art. See, for example,Yamamoto et al. (1997) Plant J. 12(2):255-265; Kwon et al. (1994) PlantPhysiol. 105:357-67; Yamamoto et al. (1994) Plant Cell Physiol.35(5):773-778; Gotor et al. (1993) Plant J. 3:509-18; Orozco et al.(1993) Plant Mol. Biol. 23(6):1129-1138; and Matsuoka et al. (1993)Proc. Natl. Acad. Sci. USA 90(20):9586-9590.

Root-preferred promoters are known in the art and can be selected fromthe many available from the literature or isolated de novo from variouscompatible species. See, for example, Hire et al. (1992) Plant Mol.Biol. 20(2):207-218 (soybean root-preferred glutamine synthetase gene);Keller and Baumgartner (1991) Plant Cell 3(10):1051-1061 (root-preferredcontrol element in the GRP 1.8 gene of French bean); Sanger et al.(1990) Plant Mol. Biol. 14(3):433-443 (root-preferred promoter of themannopine synthase (MAS) gene of Agrobacterium tumefaciens); and Miao etal. (1991) Plant Cell 3(1):11-22 (full-length cDNA clone encodingcytosolic glutamine synthetase (GS), which is expressed in roots androot nodules of soybean). See also Bogusz et al. (1990) Plant Cell2(7):633-641, where two root-preferred promoters isolated fromhemoglobin genes from the nitrogen-fixing nonlegume Parasponiaandersonii and the related non-nitrogen-fixing nonlegume Trema tomentosaare described. The promoters of these genes were linked to aβ-glucuronidase reporter gene and introduced into both the nonlegumeNicotiana tabacum and the legume Lotus corniculatus, and in bothinstances root-preferred promoter activity was preserved. Leach andAoyagi (1991) describe their analysis of the promoters of the highlyexpressed rolC and rolD root-inducing genes of Agrobacterium rhizogenes(see Plant Science (Limerick) 79(1):69-76). They concluded that enhancerand tissue-preferred DNA determinants are dissociated in thosepromoters. Teeri et al. (1989) used gene fusion to lacZ to show that theAgrobacterium T-DNA gene encoding octopine synthase is especially activein the epidermis of the root tip and that the TR2′ gene is root specificin the intact plant and stimulated by wounding in leaf tissue, anespecially desirable combination of characteristics for use with aninsecticidal or larvicidal gene (see EMBO J. 8(2):343-350). The TR1′gene, fused to nptII (neomycin phosphotransferase II) showed similarcharacteristics. Additional root-preferred promoters include theVfENOD-GRP3 gene promoter (Kuster et al. (1995) Plant Mol. Biol.29(4):759-772); and rolB promoter (Capana et al. (1994) Plant Mol. Biol.25(4):681-691). See also U.S. Pat. Nos. 5,837,876; 5,750,386; 5,633,363;5,459,252; 5,401,836; 5,110,732; and 5,023,179.

“Seed-preferred” promoters include both “seed-specific” promoters (thosepromoters active during seed development such as promoters of seedstorage proteins) as well as “seed-germinating” promoters (thosepromoters active during seed germination). See Thompson et al. (1989)BioEssays 10:108, herein incorporated by reference. For dicots,seed-preferred promoters include, but are not limited to promoters forthe phaseolin seed storage proteins (for example, bean β-phaseolinpromoter; see Riggs (1989) Plant Sci. 63:47-57; Bustos et al. (1991)EMBO J. 10:1469-1479), the napin promoter (see, for example, Radke etal. (1988) Theor. Appl. Genet. 75:685-694; Kohno-Murase et al. (1994)Plant Mol. Biol. 26:1115-1124), β-conglycinin promoter (see, forexample, Lesssard et al. (1991) Plant Mol. Biol. 16:379-413), soybeanlectin promoter (see, for example, Okamura et al. (1986) Proc. Natl.Acad. Sci. USA 83:8240-8244), glabra2 promoter (see Cameron et al.(2002) Plant Cell 14:1359-1375, and Arabidopsis thaliana glabra2promoter deposited as GenBank Accession No. L32873), 12S cruciferin seedstorage protein promoter (see Arabidopsis thaliana ATCRU3 gene depositedin GenBank as Accession No. 66916), cruciferin promoter (see Brassicanapus cruciferin promoter deposited as GenBank Accession No. M16860),the KTI promoters (see, US Application Publication No. 20040073975 andJofuku et al. (1989) Plant Cell 1:1079-1093), oleosin promoters (seeBrassica juncea oleosin promoter deposited as GenBank Accession No.AF134411, Glycine max oleosin promoter deposited as GenBank AccessionNo. U71381, and Arabidopsis thaliana oleosin promoter disclosed in U.S.Pat. No. 5,977,436; see also Plant et al. (1994) Plant Mol. Biol.25:193-205 (Arabadopsis thaliana oleosin promoter); Keddie et al. (1994)Plant Mol. Biol. 24:327-40 and Keddie et al. (1992) Plant Mol. Biol.19:443-53 (Brassica napus oleosin promoter)), and the like.Paricarp-preferred promoters include promoters such as the LTP1promoter. See, for example, WO 95/23230, herein incorporated byreference.

For monocots, such seed-preferred promoters include, but are not limitedto, maize 15 kDa zein promoter, 22 kDa zein promoter, 27 kDa zeinpromoter (see the sequence deposited as GenBank Accession No. X58197),gamma-zein promoter (gzw64A); also see the sequence deposited as GenBankAccession No. S78780), mze40-2 promoter from maize (see U.S. Pat. No.6,403,862), b22e promoter from barley (see Klemsdal et al. (1991) Mol.Gen. Genetics 228:9-16), waxy promoter, shrunken 1 and shrunken 2promoters (see, for example, Shaw et al. (1992) Plant. Physiol.98:1214-1216, and Zhong Chen et al. (2003) Proc. Natl. Acad. Sci, USA100:3525-3530), globulin 1 (glb1) promoter (see the Zea mays promoterdeposited as GenBank Accession No. L22344), oleosin promoters (see, forexample, Zea mays L3 oleosin promoter (P-ZmL3) disclosed in Hong et al.(1997) Plant Mol. Biol. 34:549-555), lipid transfer protein 2 (LTP2)promoters (for example, rice LTP2 promoter disclosed in Morino et al.(1999) Plant J. 17:275-285, barley LTP2 promoter disclosed in U.S. Pat.No. 5,525,716 and Kalla et al. (1994) Plant J. 6:849-860, and maize LTP2promoter disclosed in International Publication No. WO 00/11177), nuc1promoter (see U.S. Pat. No. 6,407,315), Zm40 promoter (see U.S. Pat. No.6,403,862), mlip 15 promoter (see U.S. Pat. No. 6,479,734), Lec1promoter (for example, maize Lec1 promoter, SEQ ID NO:9 of U.S. PatentApplication Publication No. 20040237147), maize end1 and end2 promoters(see U.S. Pat. No. 6,528,704; International Patent Publication No. WO00/12733; and U.S. patent application Ser. No. 10/310,191, filed Dec. 4,2002(now U.S. Pat. No. 6,903,205), eep1 (SEQ ID NO:7 of U.S. PatentApplication Publication No. 20040237147) and eep2 (SEQ ID NO:18 of U.S.Patent Application Publication No. 20040237147); PCNA2 promoter (SEQ IDNO:25 of U.S. Patent Application Publication No. 20040237147);thioredoxinH promoter (SEQ ID NO:19 of U.S. Patent ApplicationPublication No. 20040237147); the nucellain promoter (see Linnestad etal. (1998) Plant Physiol. 118:1169-80); the kn1 promoter (see Hake andOri, Keystone Symposia, Feb. 8-14, 1999, Abstract B8 at 27), the F3.7promoter (SEQ ID NO:10 of U.S. Patent Application Publication No.20040237147; see also Baszczynski et al. (1997) Maydica 42:189); theBETL1 promoter (see Hueros et al. (1999) Plant Physiol. 121:1143-1152and Hueros et al. (1995) Plant Cell 7:747-57); Cim1 (cytokinin-inducedmessage, which expresses in nucellus tissue; see U.S. Pat. No.6,225,529, describing the Zea mays Cim1 promoter); cZ19B1 (maize 19 kDazein; see U.S. Pat. No. 6,225,529); milps (myo-inositol-1-phosphatesynthase; see WO 00/11177 and U.S. Pat. No. 6,225,529; hereinincorporated by reference); EAP1 (early abundant protein 1; see U.S.Patent Application Publication No. 20040210043); rita-1 promoter fromrice (Izawa et al. (1994) Plant Cell 6:1277-1287); Zea mays Opaque-2promoter (Gallusci et al. (1994) Mol. Gen. Genetics 244:391-400;Kirihara et al. (1988) Mol. Gen. Genetics 211:477-484; Kirihara et al.(1988) Gene 71:359-370); cytokinin oxidase promoters (for example,ZmCkx2, ZmCkx3, ZmCkx4, and ZmCkx5 promoters set forth as SEQ ID NO:34,35, 36, and 37, respectively, of U.S. Patent Application Publication No.20040237147); and the GLB2 promoter or biologically active variants orfragments thereof (SEQ ID NO:2).

Anther-specific promoters can also be used and include, for example, atapetum-specific promoter such as the tobacco anther promoter, ant32, ananther-specific promoter such as that from LAT52 (Twell et al. (1989)Mol. Gen. Genet. 217: 240-245, and the anther specific promoter 5126(U.S. Pat. Nos. 5,689,049 and 5,689,051). Another anther-specificpromoter includes the MS45 promoter. See, U.S. Application PublicationNo. 2004/0221331, herein incorporated by reference. Pollen-preferredpromoters include, for example, the Zm13 promoter (Guerrero et al.(1993) Mol. Gen. Genet. 224: 161-168), and the SF3 promoter (U.S. Pat.No. 6,452,069). See, also, Guerrero (1990) Mol. Gen. Genet. 224:161-168.

The convergent promoters can be chosen to provide for spatiallydifferent expression profiles, for example, within the same plant partsuch as a seed. In the same manner, the promoters may be chosen toprovide temporally different expression profiles within the same plantpart, such as seed. For example, the glb1, oleosin, and EAP1 promotersprovide for expression in an embryo-preferred manner while thegamma-zein, rita-1, and Opaque-2 promoters provide for expression in anendosperm-preferred manner. The LTP2, EN2 and b22e promoters provide forexpression preferentially in the aleurone. The Cim1 and nuc1 promotersprovide for expression preferentially in the nucellus. The end1 andBETL1 promoters provide for expression preferentially in endospermtransfer cells. Other such promoters include a promoter active in theembryo-surrounding region (ESR) (see U.S. Patent Application PublicationNo. 20040210960), promoters that are preferentially active in femalereproductive tissues, and those that are active in meristematic tissues,particularly in meristematic female reproductive tissues. Thus, by usingselective promoters, careful regulation of a target polynucleotide canbe controlled.

Likewise, promoters can be selected to provide somewhat precise temporalcontrol of expression. In this manner, for example, seed-preferredpromoters that act from 0-25 days after pollination (DAP) are useful, asare those acting from 4-21, 4-12, or 8-12 days DAP. Such promotersinclude cim1, LTP2, nuc1, b22e, end1, and BETL1. Other promoters thatact from −14 to 0 DAP include SAG12 (see WO 96/29858) and ZAG1 or ZAG2(see Schmidt et al. (1993) Plant Cell 5(7):729-37 and SEQ ID NO:3 ofU.S. Patent Application Publication No. 20040237147). Other usefulpromoters that can provide temporal expression patterns include, but arenot limited to, zap (SEQ ID NO:5 of U.S. Patent Application PublicationNo. 20040237147 also known as ZmMADS; see also International PatentApplication Publication No. WO 03/078590); maize tb1 promoter (SEQ IDNO:17 of U.S. Patent Application Publication No. 20040237147; see alsoHubbarda et al. (2002) Genetics 162:1927-1935); and ODP1, oleosin, maizeend2, eep1, eep2, and lec1 promoters.

Senescence promoters may be selected to confer temporal regulation ofgenes in specific tissues including promoters for senescence-inducedreceptor-like kinase (SIRK), senescence-associated receptor-like kinase(SARK), WRKY6, and WRKY DNA-binding protein 53 (WRKY53); thesenescence-associated gene (SAG12; see, for example, U.S. Pat. Nos.5,689,042, 6,359,197, and WO 96/29858, maize lethal leaf-spot 1 (LLS-1)promoters (see, for example, U.S. Pat. No. 6,818,806).

Thus, depending on the desired results any combination of convergentpromoters can be used. While it is recognized that two identicalpromoters could be used in the suppression cassette or differentpromoter having the same expression profile, in specific embodiments,the convergent promoters will have differential expression profiles.

In still other embodiments, the suppression cassette comprises tworecombination sites which flank at least one of the silencing elementsand are internal to the convergent promoters. In this embodiment, therecombination sites can be used to allow for efficient exchange of thesilencing element. See, for example, WO99/25821, WO99/25854, WO99/25840,WO99/25855, and WO99/25853, all of which are herein incorporated byreference.

A “decreased level” or “decreasing the level” of a polynucleotide or apolypeptide in the context of the methods of the present inventionrefers to any decrease in the expression, concentration, and/or activityof a gene product (i.e., polypeptide or polynucleotide), including anyrelative increment in expression, concentration and/or activity. Theterm “expression” as used herein in the context of a gene product,refers to the biosynthesis of that product including the transcriptionor translation of the gene product. In general, the level of thepolypeptide or the polynucleotide is decreased by at least 1%, 5%, 10%,20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or greater relative to anative control plant, plant part, or cell. The expression level of thegene product of interest may be measured directly, for example, byassaying for the level of that gene product expressed in the plant orplant part thereof, or indirectly, for example, by measuring theactivity of the gene product in the plant or plant part thereof usingassays specific for the gene product of interest. The “decrease level”may occur during and/or subsequent to growth of the plant to the desiredstage of development. In specific embodiments, the polynucleotides orthe polypeptides of the present invention are modulated in monocots,particularly maize.

A “subject plant or plant cell” is one in which genetic alteration, suchas transformation, has been affected as to a polynucleotide of interest,or is a plant or plant cell which is descended from a plant or cell soaltered and which comprises the alteration. A “control” or “controlplant” or “control plant cell” provides a reference point for measuringchanges in phenotype of the subject plant or plant cell.

A control plant or plant cell may comprise, for example: (a) a wild-typeplant or cell, i.e., of the same genotype as the starting material forthe genetic alteration which resulted in the subject plant or cell; (b)a plant or plant cell of the same genotype as the starting material butwhich has been transformed with a null construct (i.e. with a constructwhich has no known effect on the trait of interest, such as a constructcomprising a marker gene); (c) a plant or plant cell which is anon-transformed segregant among progeny of a subject plant or plantcell; (d) a plant or plant cell genetically identical to the subjectplant or plant cell but which is not exposed to conditions or stimulithat would induce expression of the gene of interest; or (e) the subjectplant or plant cell itself, under conditions in which the gene ofinterest is not expressed.

The expression of the silencing elements of the invention can be usedfor example, to impart commercially important agronomic traits inplants, such as improved grain quality, improved feed value includingmore balanced amino acids and/or higher available energy, and improvedwet milling characteristics including higher oil and/or reduced fiber.In mammals, the methods of the invention can be used to treat or preventdiseases or disease states.

The suppression cassettes of the present invention can be used to targetany polynucleotide of interest or combination of polynucleotides whereina decrease of expression of the polynucleotide provides for a desirablephenotypic change in the host organism. In this manner, the silencingelement within the suppression cassette is designed such that theencoded hairpin RNA transcripts target one or more polynucleotides ofinterest including any cellular RNA (such as, but not limited to, anendogenous RNA, a viral RNA, an RNA transcribed from introduced vectorssuch as plasmids, an RNA transcribed from a transgene, and the like).

Target polynucleotides of interest include polynucleotides involved inprimary and secondary biosynthetic pathways. Thus, for example, wherethe host organism is a plant, the polynucleotide targeted forsuppression can be involved in amino acid and protein biosynthesis;nucleic acid biosynthesis; mineral nutrient uptake and transport;nitrogen and sulfur metabolism; photosynthesis and carbohydratemetabolism; cell wall biosynthesis; fatty acid metabolism; membranebiosynthesis; membrane transport processes; hormone biosynthesis;cytoskeleton biosynthesis; and the like. Other genes of interestinclude, but are not limited to, those involved in biotic and abioticstress responses; those involved in signal perception; those involved indevelopmental processes such as vegetative and reproductive growth,dormancy, and senescence and programmed death; those involved insecondary metabolism; for example, biosynthesis of alkaloids,terpenoids, and phenylpropanoids; and the like. In some embodiments, thehost organism is a plant and the polynucleotides of interest includethose involved in fatty acid metabolism.

In one embodiment, the suppression cassette of the invention can be usedto alter cell wall biosynthesis. For example, it is known that downregulating hemicellulose biosynthesis increases the digestibility offeed. Hemicellulose includes such sugars as xylan, glucuronoxylan,arabinoxylan, glucomannan, and xyloglucan. One of the enzymes involvedin hemicellulose biosynthesis via the arabinose synthetic pathway isreversibly glycosylated polypeptide-1 (RGP1). See for example, theArabidopsis thalania nucleotide sequence deposited as GenBank AccessionNo. AF013627, Delgado et al. (1998) Plant Physiol. 116:1339-1350,Langeveld et al. (2002) Plant Physiol. 129:278-289, and U.S. Pat. No.6,194,638; the Gossypium hirsutum (upland cotton) sequence deposited asGenBank Accession No. AJ292078; and the maize RGP1 nucleotide sequenceset forth in U.S. Pat. No. 6,194,638; each of these references is hereinincorporated by reference in their entirety. In other embodiments, theUSX gene is targeted for down regulation. See, for example, U.S.Provisional Application No. 60/755,253, herein incorporated by referencein its entirety.

As shown herein, suppressing the expression of RGP1 in a seed-preferredmanner decreases hemicellulose and arabinose biosynthesis. Suppressioncassette that provide for expression of RNA transcripts that inhibitRGP1 (i.e., RGP1 inhibitory transcripts) are described herein andinclude constructs expressing RNA transcripts that form stem-loopstructures, such as constructs comprising the sequence set forth in SEQID NO:2 and described herein below in Example 1. The present suppressioncassette is advantageous as it provides an efficient means to inhibitRGP1 expression in spatially separated tissues within a seed, forexample, within the endosperm (i.e., with a gamma-zein or Opaque-2promoter) and the embryo (i.e., with a globulin 1, oleosin, or EAP1promoter), and can provide for expression of the inhibitory RNAtranscripts throughout early and late seed development. See, forexample, FIG. 1 and FIG. 2 which illustrate embodiments whereininhibition of hemicellulose was targeted in both the embryo andendosperm of the transformed seed by using the oleosin promoter and thegamma-zein promoter. In other embodiments, one member of the convergentpromoter pair drives expression of the RGP1 inhibitory RNA transcriptduring early seed development, for example, the eep1 or eep2 promoter,and the other member is a promoter that drives expression of the RGP1inhibitory RNA transcript during late seed development, for example, anoleosin promoter. Use of these suppression cassette in the methods ofthe present invention can provide for decreased hemicellulose and/orarabinose content in the seed or part thereof, for example, endospermand embryo, and/or throughout early and late seed development.

In yet other embodiments of the invention, phytic acid biosynthesis canbe manipulated. Phytic acid (myo-inositol-1,2,3,4,5,6-hexakisphosphate;Ins P6) can comprise between 50% to 80% of the phosphorus in plantseeds. In maize (Zea mays) kernels, nearly 90% of the phytic acidaccumulates in the embryo, with only about 10% accumulating in thealeurone layer, and only trace amounts being found in the endosperm(O′Dell et al. (1972) J. Agric. Food. Chem. 20:718-721). In rice (Oryzasativa), barley (Hordeum vulgare), and wheat (Triticum aestivum), mostof the phytic acid (approximately 90%) is found in the aleurone layerand only about 10% accumulates in the embryo. In view of the poordigestibility of phytic acid, the diet of monogastric animals must besupplemented with inorganic phosphate (Pi) to meet their phosphorusrequirement. Poor digestibility also results in phytic acid release intothe environment, contributing to phosphorus pollution (Cromwell andCoffey (1991) in Biotechnology in the Feed Industry, ed. Lyons (AlltechTech Publishers, Nicholasville, Ky.), pp. 133-145). In view of these andother problems associated with phytic acid, reduced phytic acid contentin seeds is a desired goal for genetic improvement in several crops,including maize, rice, barley, wheat, and soybean (Glycine max). Thedown regulation of phytic acid biosynthesis can increase thedigestibility of feed, decrease the amount of phosphorus supplementationrequired in animal feeds (Ertl et al. (1998) J. Environ. Qual.27:299-304), and reduce phosphorus pollution into the environment.Reducing the phytic acid levels also improves grain wet millingcharacteristics by reducing phytic acid precipitation during the millingprocess (Pen et al. (1993) Bio/Tech. 11:811). Low-phytic acid mutantshave been generated by mutagenesis in maize, rice, barley, and soybean(Rasmussen and Hatzack (1998) Hereditas 129:107-112); Larson et al.(2000) Crop. Sci. 40:1397-1405); Raboy et al. (2000) Plant Physiol.124:355-368); Wilcox et al. (2000) Crop. Sci. 40:1601-1605). Seeds ofthe low phytic acid mutants lpa1-1 and lpa1-2 have phytic acid levelsthat are reduced over 55% relative to wild-type maize seed. See Raboy etal. (2000) Plant Physiol. 124:355-368, U.S. Pat. No. 6,111,168, and U.S.Pat. No. 5,689,054. The recombinant constructs of the present inventionprovide an alternative efficient method for generating transformedplants that produce seed having a low-phytic acid content.

Thus, by transforming a plant with an expression construct of theinvention that targets one or more genes involved in the phytic acidbiosynthesis pathway, phytic acid production in the plant seed can bedecreased throughout seed development or in the particular seed tissuesof interest. Genes involved in phytic acid biosynthesis are known in theart. Examples include, but are not limited to, the maize inositolphosphate kinase gene ZmIpk (see coding sequence disclosed in Shi et al.(2003) Plant Physiol. 131:507-515), in which Mu insertions account forthe maize lpa2 mutant phenotype; genes involved in the maize lpa1 mutantphenotype (see Raboy et al. (2000) Plant Physiol. 124:355-368, and U.S.Pat. Nos. 5,689,054 and 6,111,168); genes encoding inositolpolyphosphate kinases such as those disclosed in U.S. Patent ApplicationPublication No. 20030009011; other genes implicated in phytic acidmetabolic pathways such as myo-inositol 1-phosphate synthase (MI1PS)(see for example Glycine max MI1PS deposited in GenBank as Accession No.AY038802), inositol 1,3,4-trisphosphate 5/6 kinases (ITPKs) andmyo-inositol monophophatase (IMP) (see U.S. Patent ApplicationPublication No. 20030079247), and the like; the disclosures of which areherein incorporated by reference in their entirety.

As noted, the suppression cassettes of the invention can be used toinhibit the expression of target polynucleotides of interest. Expressionof any given polynucleotide of interest in a genetically modified plantor plant part thereof is decreased if the transcript level or theprotein level, for example, of RGP1, AGP, or FAD, is statistically lowerthan the transcript level or the protein level in a control plant.

The expression level of a polypeptide and/or an RNA may be measureddirectly, for example, by assaying for the level of the polypeptide orthe RNA in the plant, or indirectly, for example, by measuring theactivity of the polypeptide or the RNA in the plant. For example, thelevel of RGP1 can be assayed using methods disclosed herein below.Inhibiting the expression of any given gene product of interest mayoccur during and/or subsequent to growth of the plant to the desiredstage of development.

The use of the term “polynucleotide” is not intended to limit thepresent invention to polynucleotides comprising DNA. Those of ordinaryskill in the art will recognize that polynucleotides, can compriseribonucleotides and combinations of ribonucleotides anddeoxyribonucleotides. Such deoxyribonucleotides and ribonucleotidesinclude both naturally occurring molecules and synthetic analogues. Thepolynucleotides of the invention also encompass all forms of sequencesincluding, but not limited to, single-stranded forms, double-strandedforms, hairpins, stem-and-loop structures, and the like.

The suppression cassettes of the invention are introduced into cells ofinterest, for example, plant cells, mammalian cells, and the like.Subsequently, a cell having the construct of the invention is selectedusing methods known to those of skill in the art such as, but notlimited to, Southern blot analysis, DNA sequencing, PCR analysis, orphenotypic analysis. A cell altered or modified by the foregoingembodiments is grown or propagated under the proper conditions for atime sufficient to reduce the concentration and/or activity of targetRNA and polypeptides.

The suppression constructs can be constructed on vectors or DNAconstructs comprising additional cassettes designed to expressselectable markers, other genes of interest, and the like.Alternatively, additional gene(s) can be provided on multipleconstructs. Such constructs are provided with a plurality of restrictionsites and/or recombination sites for insertion of a polynucleotide to beunder the transcriptional regulation of a regulatory region. Theregulatory regions (e.g., promoters, transcriptional regulatory regions,and translational termination regions, including those within thecassette and/or the polynucleotide of interest may be native/analogousto the host cell or to each other. Alternatively, the regulatory regionsand/or the polynucleotide of interest may be heterologous to the hostcell or to each other. As used herein, “heterologous” in reference to asequence is a sequence that originates from a foreign species, or, iffrom the same species, is substantially modified from its native form incomposition and/or genomic locus by deliberate human intervention. Forexample, a heterologous promoter operably linked to a polynucleotide ofinterest is from a species different from the species from which thepromoter was derived, or, if from the same/analogous species, one orboth are substantially modified from their original form and/or genomiclocus, or the promoter is not the native promoter for the operablylinked polynucleotide.

In preparing DNA constructs, various DNA fragments may be manipulated,so as to provide for DNA sequences in the proper orientation and, asappropriate, in the proper reading frame. Toward this end, adapters orlinkers may be employed to join DNA fragments or other manipulations maybe involved to provide for convenient restriction sites, removal ofsuperfluous DNA, removal of restriction sites, or the like. For thispurpose, in vitro mutagenesis, primer repair, restriction, annealing,resubstitutions, e.g., transitions and transversions, may be involved.

In certain embodiments, a suppression cassette comprising a silencingelement of the invention can be “stacked” with any combination ofpolynucleotide of interest in order to create an organism, moreparticularly plants, with a desired phenotype. By “stacked” or“stacking” is intended that an organism, for example, a plant ofinterest, contains one or more nucleic acids collectively comprisingmultiple polynucleotides so that the transcription and/or expression ofmultiple polynucleotides are altered in the organism.

In this manner, a suppression cassette comprising the silencing elementsas disclosed herein can be stacked with any other polynucleotide(s) toproduce plants having a variety of desired trait combinations including,for example, traits desirable for animal feed such as high oil genes(see, e.g., U.S. Pat. No. 6,232,529, which is incorporated herein byreference); balanced amino acids (e.g., hordothionins; see U.S. Pat.Nos. 5,990,389; 5,885,801; 5,885,802; and 5,703,409, each of which isincorporated herein by reference); barley high lysine (Williamson et al.(1987) Eur. J. Biochem. 165: 99-106, WO 98/20122 and WO 98/20133); highmethionine proteins (Pedersen et al. (1986) J. Biol. Chem. 261: 6279;Kirihara et al. (1988) Gene 71: 359; and Musumura et al. (1989) PlantMol. Biol. 12: 123); increased digestibility (e.g., modified storageproteins) and thioredoxins (U.S. Ser. No. 10/005,429, filed Dec. 3,2001).

Suppression cassettes of the invention can also be stacked with one ormore polynucleotides encoding a desirable trait such as a polynucleotidethat confers, for example, insect, disease or herbicide resistance(e.g., Bacillus thuringiensis toxic proteins; U.S. Pat. Nos. 5,366,892;5,747,450; 5,737,514; 5,723,756; 5,593,881; Geiser et al. (1986) Gene48: 109); lectins (Van Damme et al. (1994) Plant Mol. Biol. 24: 825);fumonisin detoxification genes (U.S. Pat. No. 5,792,931); avirulence anddisease resistance genes (Jones et al. (1994) Science 266: 789; Martinet al. (1993) Science 262: 1432; Mindrinos et al. (1994) Cell 78: 1089);acetolactate synthase mutants that lead to herbicide resistance such asthe S4 and/or Hra mutations; inhibitors of glutamine synthase such asphosphinothricin or basta (e.g., the bar gene); and glyphosateresistance (EPSPS gene). Additional polynucleotides that can be stackedinclude, for example, those encoding traits desirable for processing orprocess products such as modified oils (e.g., fatty acid desaturasegenes (U.S. Pat. No. 5,952,544; WO 94/11516); modified starches (e.g.,AGPases, starch synthases, starch branching enzymes, and starchdebranching enzymes); modified cell wall amounts and/or properties(e.g., UDP-glucose dehydrogenase (U.S. Pat. No. 6,399,859), ReversiblyGlycosylated Polypeptide (RGP1) (see the Arabidopsis thalania nucleotidesequence deposited as GenBank Accession No. AF013627, Delgado et al.(1998) Plant Physiol. 116:1339-1350, Langeveld et al. (2002) PlantPhysiol. 129:278-289, and U.S. Pat. No. 6,194,638; and the Gossypiumhirsutum (upland cotton) sequence deposited as GenBank Accession No.AJ292078)); and polymers or bioplastics (e.g., U.S. Pat. No. 5,602,321).Recombinant constructs comprising a suppression cassette can be stackedwith one or more polynucleotides that provide desirable agronomic traitssuch as male sterility (e.g., U.S. Pat. No. 5,583,210), stalk strength,flowering time, or transformation technology traits such as cell cycleregulation or gene targeting (e.g., WO 99/61619; WO 00/17364; WO99/25821). Other desirable traits that are known in the art include highoil content; increased digestibility; balanced amino acid content; andhigh energy content. Such traits may refer to properties of both seedand non-seed plant tissues, or to food or feed prepared from plants orseeds having such traits.

These stacked combinations can be created by any method including butnot limited to cross breeding plants. If traits are stacked bygenetically transforming the plants, the nucleic acids of interest canbe combined at any time and in any order. Similarly, where a methodrequires more than one step to be performed, it is understood that stepsmay be performed in any order that accomplishes the desired end result.For example, a transgenic plant comprising one or more desired traitscan be used as the target to introduce further traits by subsequenttransformation. The traits can be introduced simultaneously in aco-transformation protocol with the polynucleotides of interest providedby any combination of cassettes suitable for transformation. Forexample, if two sequences will be introduced, the two sequences can becontained in separate cassettes (trans) or contained on the sametransformation cassette (cis). Transcription and/or expression of thesequences can be driven by the same promoter or by different promoters.In specific embodiments, the promoters of the suppression cassette arechosen to provide for differential profile expressions. Alternatively,traits may be stacked by transforming different plants to obtain thosetraits; the transformed plants may then be crossed together and progenymay be selected which contains all of the desired traits.

The methods of the invention involve introducing a polynucleotide into aplant. “Introducing” is intended to mean presenting to the plant thepolynucleotide in such a manner that the sequence gains access to theinterior of a cell of the plant. The methods of the invention do notdepend on a particular method for introducing a sequence into a plant,only that the polynucleotide gains access to the interior of at leastone cell of the plant. Methods for introducing polynucleotides intoplants are known in the art including, but not limited to, stabletransformation methods, transient transformation methods, andvirus-mediated methods.

“Stable transformation” is intended to mean that the nucleotideconstruct introduced into a plant integrates into the genome of theplant and is capable of being inherited by the progeny thereof.“Transient transformation” is intended to mean that a polynucleotide isintroduced into the plant and does not integrate into the genome of theplant.

Transformation protocols as well as protocols for introducingpolynucleotide sequences into plants may vary depending on the type ofplant or plant cell, i.e., monocot or dicot, targeted fortransformation. Suitable methods of introducing polynucleotides intoplant cells include microinjection (Crossway et al. (1986) Biotechniques4:320-334), electroporation (Riggs et al. (1986) Proc. Natl. Acad. Sci.USA 83:5602-5606, Agrobacterium-mediated transformation (U.S. Pat. No.5,563,055 and U.S. Pat. No. 5,981,840), direct gene transfer (Paszkowskiet al. (1984) EMBO J. 3:2717-2722), and ballistic particle acceleration(see, for example, U.S. Pat. Nos. 4,945,050; U.S. Pat. No. 5,879,918;U.S. Pat. No. 5,886,244; and, 5,932,782; Tomes et al. (1995) in PlantCell, Tissue, and Organ Culture: Fundamental Methods, ed. Gamborg andPhillips (Springer-Verlag, Berlin); McCabe et al. (1988) Biotechnology6:923-926); and Lec1 transformation (WO 00/28058). Also see Weissingeret al. (1988) Ann. Rev. Genet. 22:421-477; Sanford et al. (1987)Particulate Science and Technology 5:27-37 (onion); Christou et al.(1988) Plant Physiol. 87:671-674 (soybean); McCabe et al. (1988)Biotechnology 6:923-926 (soybean); Finer and McMullen (1991) In VitroCell Dev. Biol. 27P:175-182 (soybean); Singh et al. (1998) Theor. Appl.Genet. 96:319-324 (soybean); Datta et al. (1990) Biotechnology 8:736-740(rice); Klein et al. (1988) Proc. Natl. Acad. Sci. USA 85:4305-4309(maize); Klein et al. (1988) Biotechnology 6:559-563 (maize); U.S. Pat.Nos. 5,240,855; 5,322,783; and, 5,324,646; Klein et al. (1988) PlantPhysiol. 91:440-444 (maize); Fromm et al. (1990) Biotechnology 8:833-839(maize); Hooykaas-Van Slogteren et al. (1984) Nature (London)311:763-764; U.S. Pat. No. 5,736,369 (cereals); Bytebier et al. (1987)Proc. Natl. Acad. Sci. USA 84:5345-5349 (Liliaceae); De Wet et al.(1985) in The Experimental Manipulation of Ovule Tissues, ed. Chapman etal. (Longman, New York), pp. 197-209 (pollen); Kaeppler et al. (1990)Plant Cell Rep. 9:415-418 and Kaeppler et al. (1992) Theor. Appl. Genet.84:560-566 (whisker-mediated transformation); D'Halluin et al. (1992)Plant Cell 4:1495-1505 (electroporation); Li et al. (1993) Plant CellRep. 12:250-255 and Christou and Ford (1995) Ann. Bot. 75:407-413(rice); Osjoda et al. (1996) Nat. Biotechnol. 14:745-750 (maize viaAgrobacterium tumefaciens); all of which are herein incorporated byreference.

In specific embodiments, the suppression cassettes of the invention canbe provided to a plant using a variety of transient transformationmethods. Such methods include, for example, microinjection or particlebombardment. See, for example, Crossway et al. (1986) Mol Gen. Genet.202:179-185; Nomura et al. (1986) Plant Sci. 44:53-58; Hepler et al.(1994) Proc. Natl. Acad. Sci. USA 91: 2176-2180 and Hush et al. (1994)J. of Cell Sci. 107:775-784, all of which are herein incorporated byreference. Alternatively, the recombinant constructs comprising thesuppression cassettes can be transiently transformed into the plantusing techniques known in the art. Such techniques include viral vectorsystem and the precipitation of the polynucleotide in a manner thatprecludes subsequent release of the DNA. Thus, the transcription fromthe particle-bound DNA can occur, but the frequency with which it isreleased to become integrated into the genome is greatly reduced. Suchmethods include the use of particles coated with polyethylimine (PEI;Sigma #P3143).

In other embodiments, the recombinant constructs of the invention may beintroduced into plants by contacting plants with a virus or viralnucleic acids. Generally, such methods involve incorporating arecombinant construct of the invention within a viral DNA or RNAmolecule. Further, it is recognized that promoters of the invention alsoencompass promoters utilized for transcription by viral RNA polymerases.Methods for introducing polynucleotides into plants and expressing atranscript encoded therein, involving viral DNA or RNA molecules, areknown in the art. See, for example, U.S. Pat. Nos. 5,889,191; 5,889,190;5,866,785; 5,589,367; 5,316,931, and Porta et al. (1996) Mol.Biotechnol. 5:209-221; herein incorporated by reference.

Methods are known in the art for the targeted insertion of apolynucleotide at a specific location in the plant genome. In oneembodiment, the insertion of a recombinant construct comprising thesuppression cassette at a desired genomic location is achieved using asite-specific recombination system. See, for example, InternationalPublication Nos. WO99/25821, WO99/25854, WO99/25840, WO99/25855, andWO99/25853, all of which are herein incorporated by reference. Briefly,the suppression cassette can be contained in a transfer cassette flankedby two non-recombinogenic recombination sites. The transfer cassette isintroduced into a plant having stably incorporated into its genome atarget site which is flanked by two non-recombinogenic recombinationsites that correspond to the sites of the transfer cassette. Anappropriate recombinase is provided and the transfer cassette isintegrated at the target site. The suppression cassette is therebyintegrated at a specific chromosomal position in the plant genome.

Where the suppression cassette of the invention have been introducedinto plant cells, the transformed plant cells may be grown into plantsin accordance with conventional ways. See, for example, McCormick et al.(1986) Plant Cell Rep. 5:81-84. These plants may then be grown, andeither pollinated with the same transformed strain or different strains,and the resulting progeny having the desired phenotypic characteristicidentified. Two or more generations may be grown to ensure thatexpression of the desired phenotypic characteristic is stably maintainedand inherited and then seeds harvested to ensure expression of thedesired phenotypic characteristic has been achieved. In this manner, thepresent invention provides transformed seed (also referred to as“transgenic seed”) having a suppression cassette of the invention stablyincorporated into their genome.

In specific embodiments, the transformants will have a desired phenotypesuch as a change in oil content of the plant, a change in the starchcontent, a change in the phytic acid content, a change in hemicellulosecontent, combinations thereof, and the like upon transcription of thesuppression cassette of interest in a plant. These transformed plantsfind use in the wet milling industry. In the wet milling process, thepurpose is to fractionate the kernel and isolate chemical constituentsof economic value into their component parts. The process allows for thefractionation of starch into a highly purified form, as well as for theisolation in crude forms of other material including, for example,unrefined oil, or as a wide mix of materials that commonly receivelittle to no additional processing beyond drying. Hence, in the wetmilling process, grain is softened by steeping and cracked by grindingto release the germ from the kernels. The germ is separated from theheavier density mixture of starch, hulls, and fiber by “floating” thegerm segments free of the other substances in a centrifugation process.This allows a clean separation of the oil-bearing fraction of the grainfrom tissue fragments that contain the bulk of the starch. As it is noteconomical to extract oil on a small scale, many wet milling plants shiptheir germ to large, centralized oil production facilities. Oil isexpelled or extracted with solvents from dried germs and the remaininggerm meal is commonly mixed into corn gluten feed (CGF), a coproduct ofwet milling. Hence, starch contained within the germ is not recovered assuch in the wet milling process and is channeled to CGF. See, forexample, Anderson et al. (1982) “The Corn Milling Industry”; CRCHandbook of Processing and Utilization in Agriculture, A. Wolff, BocaRaton, Fla., CRC Press., Inc., Vol. 11, Part 1, Plant Products: 31-61and Eckhoff (Jun. 24-26, 1992) Proceedings of the 4th Corn UtilizationConference, St. Louis, Mo., printed by the National Corn GrowersAssociation, CIBA-GEIGY Seed Division, and the USDA, both of which areherein incorporated by reference.

As used herein, the term “plant” includes plant cells, plantprotoplasts, plant cell tissue cultures from which maize plant can beregenerated, plant calli, plant clumps, and plant cells that are intactin plants or parts of plants such as embryos, pollen, ovules, seeds,leaves, flowers, branches, fruit, kernels, ears, cobs, husks, stalks,roots, root tips, anthers, and the like. Grain is intended to mean themature seed produced by commercial growers for purposes other thangrowing or reproducing the species. Progeny, variants, and mutants ofthe regenerated plants are also included within the scope of theinvention, provided that these parts comprise the introducedpolynucleotides.

The present invention may be used for transformation of any plantspecies, including, but not limited to, monocots and dicots. Examples ofplant species of interest include, but are not limited to, corn (Zeamays), Brassica sp. (e.g., B. napus, B. rapa, B. juncea), particularlythose Brassica species useful as sources of seed oil, alfalfa (Medicagosativa), rice (Oryza sativa), rye (Secale cereale), sorghum (Sorghumbicolor, Sorghum vulgare), millet (e.g., pearl millet (Pennisetumglaucum), proso millet (Panicum miliaceum), foxtail millet (Setariaitalica), finger millet (Eleusine coracana), sunflower (Helianthusannuus), safflower (Carthamus tinctorius), wheat (Triticum aestivum),soybean (Glycine max), tobacco (Nicotiana tabacum), potato (Solanumtuberosum), peanuts (Arachis hypogaea), cotton (Gossypium barbadense,Gossypium hirsutum), sweet potato (Ipomoea batatus), cassava (Manihotesculenta), coffee (Coffea spp.), coconut (Cocos nucifera), pineapple(Ananas comosus), citrus trees (Citrus spp.), cocoa (Theobroma cacao),tea (Camellia sinensis), banana (Musa spp.), avocado (Persea americana),fig (Ficus casica), guava (Psidium guajava), mango (Mangifera indica),olive (Olea europaea), papaya (Carica papaya), cashew (Anacardiumoccidentale), macadamia (Macadamia integrifolia), almond (Prunusamygdalus), sugar beets (Beta vulgaris), sugarcane (Saccharum spp.),oats, barley, vegetables, ornamentals, and conifers.

Vegetables include tomatoes (Lycopersicon esculentum), lettuce (e.g.,Lactuca sativa), green beans (Phaseolus vulgaris), lima beans (Phaseoluslimensis), peas (Lathyrus spp.), and members of the genus Cucumis suchas cucumber (C. sativus), cantaloupe (C. cantalupensis), and musk melon(C. melo). Ornamentals include azalea (Rhododendron spp.), hydrangea(Macrophylla hydrangea), hibiscus (Hibiscus rosasanensis), roses (Rosaspp.), tulips (Tulipa spp.), daffodils (Narcissus spp.), petunias(Petunia hybrida), carnation (Dianthus caryophyllus), poinsettia(Euphorbia pulcherrima), and chrysanthemum.

Conifers that may be employed in practicing the present inventioninclude, for example, pines such as loblolly pine (Pinus taeda), slashpine (Pinus elliotii), ponderosa pine (Pinus ponderosa), lodgepole pine(Pinus contorta), and Monterey pine (Pinus radiata), Douglas-fir(Pseudotsuga menziesii), Western hemlock (Tsuga canadensis), Sitkaspruce (Picea glauca), redwood (Sequoia sempervirens), true firs such assilver fir (Abies amabilis) and balsam fir (Abies balsamea), and cedarssuch as Western red cedar (Thuja plicata) and Alaska yellow-cedar(Chamaecyparis nootkatensis). In specific embodiments, plants of thepresent invention are crop plants (for example, corn, alfalfa,sunflower, Brassica, soybean, cotton, safflower, peanut, sorghum, wheat,millet, tobacco, etc.). In other embodiments, corn and soybean plantsare optimal, and in yet other embodiments corn plants are optimal.

II. Glb2 Promoter Sequences and Variants Thereof and Methods of Use

The invention further relates to compositions and methods drawn to plantpromoters and methods of their use. The compositions comprisepolynucleotides for the promoter of the Mr 45,000 globulin component(Glb2) gene. The compositions further comprise DNA constructs comprisinga nucleotide sequence for the promoter region of the Glb2 gene operablylinked to a heterologous nucleotide sequence of interest. In particular,the present invention provides for isolated polynucleotides comprisingthe nucleotide sequence set forth in SEQ ID NO:3.

The Gbl2 promoter sequences of the present invention includepolynucleotide constructs that allow initiation of transcription in aplant. In specific embodiments, the Gbl2 promoter sequence allowsinitiation of transcription in a tissue-preferred, more particularly inan embryo-preferred manner. In specific embodiments, the Gbl2 promotersequence allows initiation of transcription in the embryo at 20 DAPthrough 34 DAP. Thus, the compositions of the present invention comprisenovel plant promoter polynucleotides, particularly embryo-preferredpromoter sequences for the Gbl2 gene, more particularly a maize Gbl2promoter sequence. The sequence for the maize Gbl2 promoter region isset forth in SEQ ID NO:3.

Compositions of the invention include the nucleotide sequences for thenative Gbl2 promoter and fragments and variants thereof. The promotersequences of the invention are useful for expressing sequences. Inspecific embodiments, the promoter sequences of the invention are usefulfor expressing sequences of interest in a tissue-preferred, particularlyan embryo-preferred manner. The sequences of the invention also find usein the construction of expression vectors for subsequent expression of aheterologous nucleotide sequence in a plant of interest or as probes forthe isolation of other Gbl2-like promoters.

The invention encompasses isolated or substantially purified nucleicacid compositions. An “isolated” or “purified” nucleic acid molecule orbiologically active portion thereof, is substantially free of othercellular material, or culture medium when produced by recombinanttechniques, or substantially free of chemical precursors or otherchemicals when chemically synthesized. An “isolated” nucleic acid isfree of sequences (optimally protein encoding sequences) that naturallyflank the nucleic acid (i.e., sequences located at the 5′ and 3′ ends ofthe nucleic acid) in the genomic DNA of the organism from which thenucleic acid is derived. For example, in various embodiments, theisolated nucleic acid molecule can contain less than about 5 kb, 4 kb, 3kb, 2 kb, 1 kb, 0.5 kb, or 0.1 kb of nucleotide sequences that naturallyflank the nucleic acid molecule in genomic DNA of the cell from whichthe nucleic acid is derived. The Gbl2 promoter sequences of theinvention may be isolated from the 5′ untranslated region flanking theirrespective transcription initiation sites.

Fragments and variants of the disclosed promoter sequences are alsoencompassed by the present invention. In particular, fragments andvariants of the Gbl2 promoter sequence of SEQ ID NO:3 may be used in theDNA constructs of the invention. As used herein, the term “fragment”means a portion of the nucleic acid sequence. Fragments of a Gbl2promoter sequence may retain the biological activity of initiatingtranscription. Alternatively, fragments of a nucleotide sequence that isuseful as hybridization probes may not necessarily retain biologicalactivity. Fragments of a nucleotide sequence for the promoter region ofthe Gbl2 gene may range from at least about 20 nucleotides, about 30nucleotides, about 40 nucleotides, about 50 nucleotides, about 60nucleotides, about 70 nucleotides, about 80 nucleotides, about 90nucleotides, about 100 nucleotides, about 150 nucleotides, about 175nucleotides, and up to the full-length nucleotide sequence of theinvention for the promoter region of the gene.

A biologically active portion of a Gbl2 promoter can be prepared byisolating a portion of the Gbl2 promoter sequence of the invention, andassessing the promoter activity of the fragment. Polynucleotides thatare fragments of a Gbl2 promoter nucleotide sequence comprise at leastabout 16, 20, 40, 50, 65, 75, 80, 90, 100, 125, 150, 175, 200, 225, 250,275, 300, 350, 400, 450, 500, 550, 600, 650 nucleotides, or up to thenumber of nucleotides present in a full-length Gbl2 promoter sequencedisclosed herein.

As used herein, the term “variants” means substantially similarsequences. For nucleotide sequences, naturally occurring variants can beidentified with the use of well-known molecular biology techniques, suchas, for example, with polymerase chain reaction (PCR) and hybridizationtechniques as outlined herein. For nucleotide sequences, a variantcomprises a deletion and/or addition of one or more nucleotides at oneor more internal sites within the native polynucleotide and/or asubstitution of one or more nucleotides at one or more sites in thenative polynucleotide. As used herein, a “native” nucleotide sequencecomprises a naturally occurring nucleotide sequence. For nucleotidesequences, naturally occurring variants can be identified with the useof well-known molecular biology techniques, as, for example, withpolymerase chain reaction (PCR) and hybridization techniques as outlinedbelow. Variant nucleotide sequences also include synthetically derivednucleotide sequences, such as those generated, for example, by usingsite-directed mutagenesis. Generally, variants of a particularnucleotide sequence of the invention will have at least about 40%, 45%,50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%,96%, 97%, 98%, 99% or more sequence identity to that particularnucleotide sequence as determined by sequence alignment programs andparameters described elsewhere herein. A biologically active variant ofa nucleotide sequence of the invention may differ from that sequence byas few as 1-15 nucleic acid residues, as few as 1-10, such as 6-10, asfew as 5, as few as 4, 3, 2, or even 1 nucleic acid residue.

Variant polynucleotides also encompass sequences derived from amutagenic and recombinogenic procedure such as DNA shuffling. With sucha procedure, one or more different Gbl2 nucleotide sequences for thepromoter can be manipulated to create a new Gbl2 promoter. In thismanner, libraries of recombinant polynucleotides are generated from apopulation of related sequence polynucleotides comprising sequenceregions that have substantial sequence identity and can be homologouslyrecombined in vitro or in vivo. Strategies for such DNA shuffling areknown in the art. See, for example, Stemmer (1994) Proc. Natl. Acad.Sci. USA 91:10747-10751; Stemmer (1994) Nature 370:389-391; Crameri etal. (1997) Nature Biotech. 15:436-438; Moore et al. (1997) J. Mol. Biol.272:336-347; Zhang et al. (1997) Proc. Natl. Acad. Sci. USA94:4504-4509; Crameri et al. (1998) Nature 391:288-291; and U.S. Pat.Nos. 5,605,793 and 5,837,458.

The nucleotide sequences of the invention can be used to isolatecorresponding sequences from other organisms, particularly other plants,more particularly other monocots. In this manner, methods such as PCR,hybridization, and the like can be used to identify such sequences basedon their sequence homology to the sequences set forth herein. Sequencesisolated based on their sequence identity to the entire Gbl2 sequencesset forth herein or to fragments thereof are encompassed by the presentinvention.

In a PCR approach, oligonucleotide primers can be designed for use inPCR reactions to amplify corresponding DNA sequences from genomic DNAextracted from any plant of interest. Methods for designing PCR primersand PCR cloning are generally known in the art and are disclosed inSambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed.,Cold Spring Harbor Laboratory Press, Plainview, N.Y.), hereinafterSambrook. See also Innis et al., eds. (1990) PCR Protocols: A Guide toMethods and Applications (Academic Press, New York); Innis and Gelfand,eds. (1995) PCR Strategies (Academic Press, New York); and Innis andGelfand, eds. (1999) PCR Methods Manual (Academic Press, New York).Known methods of PCR include, but are not limited to, methods usingpaired primers, nested primers, single specific primers, degenerateprimers, gene-specific primers, vector-specific primers,partially-mismatched primers, and the like.

In hybridization techniques, all or part of a known nucleotide sequenceis used as a probe that selectively hybridizes to other correspondingnucleotide sequences present in a population of cloned genomic DNAfragments from a chosen organism. The hybridization probes may belabeled with a detectable group such as ³²P, or any other detectablemarker. Thus, for example, probes for hybridization can be made bylabeling synthetic oligonucleotides based on the Gbl2 promoter sequencesof the invention. Methods for preparation of probes for hybridizationand for construction of genomic libraries are generally known in the artand are disclosed in Sambrook.

For example, the entire Gbl2 promoter sequence disclosed herein, or oneor more portions thereof, may be used as a probe capable of specificallyhybridizing to corresponding Gbl2 promoter sequences and messenger RNAs.To achieve specific hybridization under a variety of conditions, suchprobes include sequences that are unique among Gbl2 promoter sequencesand are at least about 10 nucleotides in length or at least about 20nucleotides in length. Such probes may be used to amplify correspondingGbl2 promoter sequences from a chosen plant by PCR. This technique maybe used to isolate additional coding sequences from a desired organismor as a diagnostic assay to determine the presence of coding sequencesin an organism. Hybridization techniques include hybridization screeningof plated DNA libraries (either plaques or colonies; see, for example,Sambrook et al. (1989) Cloning: A Laboratory Manual (2^(nd) ed, ColdSpring Harbor Laboratory Press, Plainview, N.Y.)

Hybridization of such sequences may be carried out under stringentconditions. The terms “stringent conditions” and “stringenthybridization conditions” are intended to mean conditions under which aprobe will hybridize to its target sequence to a detectably greaterdegree than to other sequences (e.g., at least 2-fold over background).Stringent conditions are sequence-dependent and will be different indifferent circumstances. By controlling the stringency of thehybridization and/or washing conditions, target sequences that are 100%complementary to the probe can be identified (homologous probing).Alternatively, stringency conditions can be adjusted to allow somemismatching in sequences so that lower degrees of similarity aredetected (heterologous probing). Generally, a probe is less than about1000 nucleotides in length or less than 500 nucleotides in length.

Typically, stringent conditions will be those in which the saltconcentration is less than about 1.5 M Na ion, typically about 0.01 to1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3 and thetemperature is at least about 30° C. for short probes (e.g., 10 to 50nucleotides) and at least about 60° C. for long probes (e.g., greaterthan 50 nucleotides). Stringent conditions may also be achieved with theaddition of destabilizing agents such as formamide. Exemplary lowstringency conditions include hybridization with a buffer solution of 30to 35% formamide, 1 M NaCl, 1% SDS (sodium dodecyl sulphate) at 37° C.,and a wash in 1× to 2×SSC (20×SSC=3.0 M NaCl/0.3 M trisodium citrate) at50 to 55° C. Exemplary moderate stringency conditions includehybridization in 40 to 45% formamide, 1.0 M NaCl, 1% SDS at 37° C., anda wash in 0.5× to 1×SSC at 55 to 60° C. Exemplary high stringencyconditions include hybridization in 50% formamide, 1 M NaCl, 1% SDS at37° C., and a final wash in 0.1×SSC at 60 to 65° C. for a duration of atleast 30 minutes. Duration of hybridization is generally less than about24 hours, usually about 4 to about 12 hours. The duration of the washtime will be at least a length of time sufficient to reach equilibrium.

Specificity is typically the function of post-hybridization washes, thecritical factors being the ionic strength and temperature of the finalwash solution. For DNA-DNA hybrids, the T_(m) (thermal melting point)can be approximated from the equation of Meinkoth and Wahl (1984) Anal.Biochem. 138:267-284: T_(m)=81.5° C.+16.6 (log M)+0.41 (% GC)−0.61 (%form)−500/L; where M is the molarity of monovalent cations, % GC is thepercentage of guanosine and cytosine nucleotides in the DNA, % form isthe percentage of formamide in the hybridization solution, and L is thelength of the hybrid in base pairs. The T_(m) is the temperature (underdefined ionic strength and pH) at which 50% of a complementary targetsequence hybridizes to a perfectly matched probe. T_(m) is reduced byabout 1° C. for each 1% of mismatching; thus, T_(m), hybridization,and/or wash conditions can be adjusted to hybridize to sequences of thedesired identity. For example, if sequences with ≧90% identity aresought, the T_(m) can be decreased 10° C. Generally, stringentconditions are selected to be about 5° C. lower than the T_(m) for thespecific sequence and its complement at a defined ionic strength and pH.However, severely stringent conditions can utilize a hybridizationand/or wash at 1, 2, 3, or 4° C. lower than the T_(m); moderatelystringent conditions can utilize a hybridization and/or wash at 6, 7, 8,9, or 10° C. lower than the T_(m); low stringency conditions can utilizea hybridization and/or wash at 11, 12, 13, 14, 15, or 20° C. lower thanthe T_(m). Using the equation, hybridization and wash compositions, anddesired T_(m), those of ordinary skill will understand that variationsin the stringency of hybridization and/or wash solutions are inherentlydescribed. If the desired degree of mismatching results in a T_(m) ofless than 45° C. (aqueous solution) or 32° C. (formamide solution), itis preferred to increase the SSC concentration so that a highertemperature can be used. An extensive guide to the hybridization ofnucleic acids is found in Tijssen (1993) Laboratory Techniques inBiochemistry and Molecular Biology—Hybridization with Nucleic AcidProbes, Part I, Chapter 2 (Elsevier, New York); and Ausubel et al., eds.(1995) Current Protocols in Molecular Biology, Chapter 2 (GreenePublishing and Wiley-Interscience, New York). See also Sambrook.

Thus, isolated sequences that have embryo-preferred promoter activityand which hybridize under stringent conditions to the Gbl2 promotersequences disclosed herein, or to fragments thereof, are encompassed bythe present invention. Generally, stringent conditions are selected tobe about 5° C. lower than the T_(m) for the specific sequence at adefined ionic strength and pH. However, stringent conditions encompasstemperatures in the range of about 1° C. to about 20° C. lower than theT_(m), depending upon the desired degree of stringency as otherwisequalified herein.

Heterologous coding sequences expressed by the Gbl2 promoters of theinvention may be used for varying the phenotype of a plant. Variouschanges in phenotype are of interest including modifying expression of agene in a plant embryo, altering a plant's pathogen or insect defensemechanism, increasing the plants tolerance to herbicides in a plant,altering embryo development to respond to environmental stress, and thelike. These results can be achieved by the expression of a heterologousnucleotide sequence of interest comprising an appropriate gene product.In specific embodiments, the heterologous nucleotide sequence ofinterest is an endogenous plant sequence whose expression level isincreased in the plant or plant part, such as the embryo. Alternatively,the results can be achieved by providing for a reduction of expressionof one or more endogenous gene products, particularly enzymes,transporters, or cofactors. These changes can result in a change inphenotype of the transformed plant.

General categories of polynucleotides of interest for the presentinvention include, for example, those genes involved in information,such as zinc fingers, those involved in communication, such as kinases,and those involved in housekeeping, such as heat shock proteins. Morespecific categories of transgenes, for example, include genes encodingimportant traits for agronomics, insect resistance, disease resistance,herbicide resistance, and environmental stress resistance (alteredtolerance to cold, salt, drought, etc). It is recognized that any geneof interest can be operably linked to the promoter of the invention andexpressed in the plant.

Insect resistance genes may encode resistance to pests that have greatyield drag such as rootworm, cutworm, European corn borer, and the like.Such genes include, for example, Bacillus thuringiensis toxic proteingenes (U.S. Pat. Nos. 5,366,892; 5,747,450; 5,736,514; 5,723,756;5,593,881; and Geiser et al. (1986) Gene 48:109); and the like.

Genes encoding disease resistance traits include detoxification genes,such as those which detoxify fumonisin (U.S. Pat. No. 5,792,931);avirulence (avr) and disease resistance (R) genes (Jones et al. (1994)Science 266:789; Martin et al. (1993) Science 262:1432; and Mindrinos etal. (1994) Cell 78:1089); and the like.

Herbicide resistance traits may include genes coding for resistance toherbicides that act to inhibit the action of acetolactate synthase(ALS), in particular the sulfonylurea-type herbicides (e.g., theacetolactate synthase (ALS) gene containing mutations leading to suchresistance, in particular the S4 and/or Hra mutations), genes coding forresistance to herbicides that act to inhibit action of glutaminesynthase, such as phosphinothricin or basta (e.g., the bar gene),glyphosate (e.g., the EPSPS gene and the GAT gene; see, for example,U.S. Publication No. 20040082770 and WO 03/092360) or other such genesknown in the art. The bar gene encodes resistance to the herbicidebasta, the nptII gene encodes resistance to the antibiotics kanamycinand geneticin, and the ALS gene mutants encode resistance to theherbicide chlorsulfuron.

Glyphosate resistance is imparted by mutant 5-enolpyruvl-3-phosphikimatesynthase (EPSP) and aroA genes. See, for example, U.S. Pat. No.4,940,835 to Shah et al., which discloses the nucleotide sequence of aform of EPSPS which can confer glyphosate resistance. U.S. Pat. No.5,627,061 to Barry et al. also describes genes encoding EPSPS enzymes.See also U.S. Pat. Nos. 6,248,876 B1; 6,040,497; 5,804,425; 5,633,435;5,145,783; 4,971,908; 5,312,910; 5,188,642; 4,940,835; 5,866,775;6,225,114 B1; 6,130,366; 5,310,667; 4,535,060; 4,769,061; 5,633,448;5,510,471; Re. 36,449; RE 37,287 E; and 5,491,288; and internationalpublications WO 97/04103; WO 97/04114; WO 00/66746; WO 01/66704; WO00/66747 and WO 00/66748, which are incorporated herein by reference forthis purpose. Glyphosate resistance is also imparted to plants thatexpress a gene that encodes a glyphosate oxido-reductase enzyme asdescribed more fully in U.S. Pat. Nos. 5,776,760 and 5,463,175, whichare incorporated herein by reference for this purpose. In additionglyphosate resistance can be imparted to plants by the over expressionof genes encoding glyphosate N-acetyltransferase. See, for example, U.S.patent application Ser. No. 10/004,357, (now U.S. ApplicationPublication No. 2003-0083480 A1), and U.S. patent application Ser. No.10/427,692 (Now U.S. Pat. No. 7,462,481)

Exogenous products include plant enzymes and products as well as thosefrom other sources including prokaryotes and other eukaryotes. Suchproducts include enzymes, cofactors, hormones, and the like.

Examples of other applicable genes and their associated phenotypeinclude the gene which encodes viral coat protein and/or RNA, or otherviral or plant genes that confer viral resistance; genes that conferfungal resistance; genes that promote yield improvement; and genes thatprovide for resistance to stress, such as cold, dehydration resultingfrom drought, heat and salinity, toxic metal or trace elements, or thelike.

As noted, the heterologous polynucleotide operably linked to the Gbl2promoters disclosed herein may be an antisense sequence for a targetedgene. Thus the promoter sequences disclosed herein may be operablylinked to antisense DNA sequences to reduce or inhibit expression of anative protein in the plant embryo.

“RNAi” refers to a series of related techniques to reduce the expressionof genes (See for example U.S. Pat. No. 6,506,559). Older techniquesreferred to by other names are now thought to rely on the samemechanism, but are given different names in the literature. Theseinclude “antisense inhibition,” the production of antisense RNAtranscripts capable of suppressing the expression of the target protein,and “co-suppression” or “sense-suppression,” which refer to theproduction of sense RNA transcripts capable of suppressing theexpression of identical or substantially similar foreign or endogenousgenes (U.S. Pat. No. 5,231,020, incorporated herein by reference). Suchtechniques rely on the use of constructs resulting in the accumulationof double stranded RNA with one strand complementary to the target geneto be silenced. The Gbl2 promoters of the embodiments may be used todrive expression of constructs that will result in RNA interferenceincluding microRNAs and siRNAs.

The term “promoter” or “transcriptional initiation region” is intendedto mean a regulatory region of DNA usually comprising a TATA box capableof directing RNA polymerase II to initiate RNA synthesis at theappropriate transcription initiation site for a particular codingsequence. A promoter may additionally comprise other recognitionsequences generally positioned upstream or 5′ to the TATA box, referredto as upstream promoter elements, which influence the transcriptioninitiation rate. It is recognized that having identified the nucleotidesequences for the promoter regions disclosed herein, it is within thestate of the art to isolate and identify further regulatory elements inthe 5′ untranslated region upstream from the particular promoter regionsidentified herein. Additionally, chimeric promoters may be provided.Such chimeras include portions of the promoter sequence fused tofragments and/or variants of heterologous transcriptional regulatoryregions. Thus, the promoter regions disclosed herein can compriseupstream regulatory elements such as, those responsible for tissue andtemporal expression of the coding sequence, enhancers and the like. Inthe same manner, the promoter elements, which enable expression in thedesired tissue, such as the embryo, can be identified, isolated and usedwith other core promoters to confer embryo-preferred expression. In thisaspect of the invention, a “core promoter” is intended to mean apromoter without promoter elements.

In the context of this disclosure, the term “regulatory element” alsorefers to a sequence of DNA, usually, but not always, upstream (5′) tothe coding sequence of a structural gene, which includes sequences whichcontrol the expression of the coding region by providing the recognitionfor RNA polymerase and/or other factors required for transcription tostart at a particular site. An example of a regulatory element thatprovides for the recognition for RNA polymerase or other transcriptionalfactors to ensure initiation at a particular site is a promoter element.A promoter element comprises a core promoter element, responsible forthe initiation of transcription, as well as other regulatory elements(as discussed elsewhere in this application) that modify geneexpression. It is to be understood that nucleotide sequences, locatedwithin introns, or 3′ of the coding region sequence may also contributeto the regulation of expression of a coding region of interest. Examplesof suitable introns include, but are not limited to, the maize IVS6intron, or the maize actin intron. A regulatory element may also includethose elements located downstream (3′) to the site of transcriptioninitiation, or within transcribed regions, or both. In the context ofthe present invention a post-transcriptional regulatory element mayinclude elements that are active following transcription initiation, forexample translational and transcriptional enhancers, translational andtranscriptional repressors, and mRNA stability determinants.

The regulatory elements, or variants or fragments thereof, of thepresent invention may be operatively associated with heterologousregulatory elements or promoters in order to modulate the activity ofthe heterologous regulatory element. Such modulation includes enhancingor repressing transcriptional activity of the heterologous regulatoryelement, modulating post-transcriptional events, or either enhancing orrepressing transcriptional activity of the heterologous regulatoryelement, and modulating post-transcriptional events. For example, one ormore regulatory elements, or fragments thereof, of the present inventionmay be operatively associated with constitutive, inducible, ortissue-specific promoters or fragment thereof, to modulate the activityof such promoters within desired tissues in plant cells.

The regulatory sequences of the present invention, or variants orfragments thereof, when operably linked to a heterologous nucleotidesequence of interest can drive embryo-preferred expression of theheterologous nucleotide sequence in the embryo of the plant expressingthis construct. The term “embryo-preferred” is intended to mean thatexpression of the heterologous nucleotide sequence is most abundant inthe embryo or a part of the embryo, While some level of expression ofthe heterologous nucleotide sequence may occur in other plant tissuetypes, expression occurs most abundantly in the embryo or embryo part.

A “heterologous polynucleotide” is intended to mean a sequence that isnot naturally occurring with the promoter sequence of the invention.While this nucleotide sequence is heterologous to the promoter sequence,it may be homologous, or native, or heterologous, or foreign, to theplant host.

The isolated promoter sequences of the present invention can be modifiedto provide for a range of expression levels of the heterologouspolynucleotide. Thus, less than the entire promoter regions may beutilized and the ability to drive expression of the nucleic acidsequence of interest retained. It is recognized that expression levelsof the mRNA may be altered in different ways by deletions of portions ofthe promoter sequences. The mRNA expression levels may be decreased, oralternatively, expression may be increased as a result of promoterdeletions if, for example, there is a negative regulatory element (for arepressor) that is removed during the truncation process.

Generally, at least about 20 nucleotides of an isolated promotersequence will be used to drive expression of a nucleotide sequence.

It is recognized that to increase transcription levels, enhancers may beutilized in combination with the promoter regions of the invention.Enhancers are nucleotide sequences that act to increase the expressionof a promoter region. Enhancers are known in the art and include theSV40 enhancer region, the 35S enhancer element, and the like. Someenhancers are also known to alter normal promoter expression patterns,for example, by causing a promoter to be expressed constitutively whenwithout the enhancer, the same promoter is expressed only in onespecific tissue or a few specific tissues.

Modifications of the isolated promoter sequences of the presentinvention can provide for a range of expression of the heterologousnucleotide sequence. Thus, they may be modified to be weak promoters orstrong promoters. Generally, a “weak promoter” is intended to mean apromoter that drives expression of a coding sequence at a low level. A“low level” of expression is intended to mean expression at levels ofabout 1/10,000 transcripts to about 1/100,000 transcripts to about1/500,000 transcripts. Conversely, a strong promoter drives expressionof a coding sequence at a high level, or at about 1/10 transcripts toabout 1/100 transcripts to about 1/1,000 transcripts.

It is recognized that the promoters of the invention may be used withtheir native Gbl2 coding sequences to increase or decrease expression,thereby resulting in a change in phenotype of the transformed plant.This phenotypic change could further affect an increase or decrease inlevels of metal ions in tissues of the transformed plant.

The nucleotide sequences disclosed in the present invention, as well as,variants and fragments thereof, are useful in the genetic manipulationof any plant. The Gbl2 promoter sequences are useful in this aspect whenoperably linked with a heterologous nucleotide sequence whose expressionis to be controlled to achieve a desired phenotypic response. In thismanner, the nucleotide sequences for the promoters of the invention maybe provided in expression cassettes along with heterologous nucleotidesequences of interest for expression in the plant of interest, moreparticularly in the embryo of the plant.

Such expression cassettes will comprise a transcriptional initiationregion comprising one of the promoter nucleotide sequences of thepresent invention, or variants or fragments thereof, operably linked tothe heterologous nucleotide sequence. Such an expression cassette can beprovided with a plurality of restriction sites for insertion of thenucleotide sequence to be under the transcriptional regulation of theregulatory regions. The expression cassette may additionally containselectable marker genes as well as 3′ termination regions.

The expression cassette can include, in the 5′-3′ direction oftranscription, a transcriptional initiation region (i.e., a promoter, orvariant or fragment thereof, of the invention), a translationalinitiation region, a heterologous nucleotide sequence of interest, atranslational termination region and, optionally, a transcriptionaltermination region functional in the host organism. The regulatoryregions (i.e., promoters, transcriptional regulatory regions, andtranslational termination regions) and/or the polynucleotide of theembodiments may be native/analogous to the host cell or to each other.Alternatively, the regulatory regions and/or the polynucleotide of theembodiments may be heterologous to the host cell or to each other.

While it may be preferable to express a heterologous nucleotide sequenceusing the promoters of the invention, the native sequences may beexpressed. Such constructs would change expression levels of the Gbl2protein in the plant or plant cell. Thus, the phenotype of the plant orplant cell can be altered.

The termination region may be native with the transcriptional initiationregion, may be native with the operably linked DNA sequence of interest,may be native with the plant host, or may be derived from another source(i.e., foreign or heterologous to the promoter, the DNA sequence beingexpressed, the plant host, or any combination thereof). Exemplarytermination sequences are discussed elsewhere herein.

The expression cassette comprising the sequences of the presentinvention may also contain at least one additional nucleotide sequencefor a gene to be cotransformed into the organism. Alternatively, theadditional sequence(s) can be provided on another expression cassette.

The expression cassettes may additionally contain 5′ leader sequences.Such leader sequences can act to enhance translation. Translationleaders are known in the art and include: picornavirus leaders, forexample, EMCV leader (Encephalomyocarditis 5′ noncoding region)(Elroy-Stein et al. (1989) Proc. Nat. Acad. Sci. USA 86:6126-6130);potyvirus leaders, for example, TEV leader (Tobacco Etch Virus) (Allisonet al. (1986) Virology 154:9-20)); MDMV leader (Maize Dwarf MosaicVirus); human immunoglobulin heavy-chain binding protein (BiP) (Macejaket al. (1991) Nature 353:90-94); untranslated leader from the coatprotein mRNA of alfalfa mosaic virus (AMV RNA 4) (Jobling et al. (1987)Nature 325:622-625); tobacco mosaic virus leader (TMV) (Gallie et al.(1989) Molecular Biology of RNA, pages 237-256); and maize chloroticmottle virus leader (MCMV) (Lommel et al. (1991) Virology 81:382-385).See also Della-Cioppa et al. (1987) Plant Physiology 84:965-968. Methodsknown to enhance mRNA stability can also be utilized, for example,introns, such as the maize Ubiquitin intron (Christensen and Quail(1996) Transgenic Res. 5:213-218; Christensen et al. (1992) PlantMolecular Biology 18:675-689) or the maize AdhI intron (Kyozuka et al.(1991) Mol. Gen. Genet. 228:40-48; Kyozuka et al. (1990) Maydica35:353-357), and the like.

Reporter genes or selectable marker genes may be included in theexpression cassettes. Examples of suitable reporter genes known in theart can be found in, for example, Jefferson et al. (1991) in PlantMolecular Biology Manual, ed. Gelvin et al. (Kluwer AcademicPublishers), pp. 1-33; DeWet et al. (1987) Mol. Cell. Biol. 7:725-737;Goff et al. (1990) EMBO J. 9:2517-2522; Kain et al. (1995) BioTechniques19:650-655; and Chiu et al. (1996) Current Biology 6:325-330.

The expression cassette comprising the Gbl2 promoter of the presentinvention, operably linked to a polynucleotide of interest, can be usedto transform any plant. In this manner, genetically modified plants,plant cells, plant tissue, seed, embryos, and the like can be obtained.

The following examples are offered by way of illustration and not by wayof limitation.

EXPERIMENTAL Example 1 Suppression Cassette Provides for DifferentialPromoter Expression of Reversibly Glycosylated Polypeptide-1 (RGP1)

The maize RGP1 gene encodes a polypeptide that is involved inhemicellulose production (see, for example, U.S. Pat. No. 6,194,638,herein incorporated by reference in its entirety). An inverted repeatcomprising a sense and antisense sequence of the maize RGP1 gene wascreated using standard molecular biology protocols. A 277 base pair (bp)HindIII-ApaI fragment from the 5′ end of the RGP1 coding sequence wasligated into a cloning intermediate. This plasmid was restrictiondigested, the end filled in with Klenow enzyme, and then digested with asecond restriction enzyme. Into this backbone, a second fragment of RGP1(an 848 by BamHI/HpaI fragment, also from the 5′ end of the codingsequence) was ligated, such that the second fragment was in reverseorientation relative to the first fragment. The suppression cassette wascreated by moving the promoter from the maize 16 kDa oleosin gene (OLEPRO; a BamHI/BglII fragment (969 bp)) into a cloning intermediatevector. From this, the OLE PRO was moved as a 997 by HpaI/HindIIIfragment into a GZ-W64A PRO cassette (from the maize 27 kDa gamma-zeingene), replacing the GZ-W64A terminator sequence. The resulting vectorcomprised the two promoters directed toward each other, separated by amulti-cloning site. The RGP1 inverted repeat fragment was ligated as a1129 by BamHI fragment into BglII-digested plasmid. The entirepromoter:inverted repeat:promoter cassette (SEQ ID NO:1) was finallymoved as a BstEII fragment into a BstEII-digested binary vector (PlasmidA; FIG. 1). This plasmid was transferred by electroporation intoelectro-competent Agrobacterium tumefaciens cells, where cos-specificrecombination with a resident vir plasmid resulted in the formation of acointegrate plasmid (Plasmid B, FIG. 2). Immature embryos of maize(GS3×HG69) were transformed using Agrobacterium tumefaciens cellscarrying Plasmid B.

Hemicellulose Assay

Seed Dissection

Nineteen mature kernels from each transformation event were soakedovernight in water at 4° C. The seeds were cut in half and dissectedinto embryo and endosperm. The dissected embryo and endosperm were driedin a lyophilizer. One-half of each endosperm or embryo was used forWestern blotting and the remaining half was used for hemicelluloseanalysis.

Western Blots

One-half of the embryo or endosperm was placed into a 96-well matrixsnap rack (Matrix Technologies #4147). The tissue was ground in the SpexCertiprep GenoGrinder for two minutes at 1400 strokes/minute or untilground. One milliliter of extraction buffer (50 mM Tris, 100 mM DTT, 2%SDS) was added to each endosperm sample or 0.5 milliliter for embryosamples. The samples were ground again for 1 minute at 1400strokes/minute in the GenoGrinder. The samples were heated at 100° C.for 5 minutes and centrifuged at 4,000 rpm for 10 minutes. Thirtymicroliters of supernatant was added to 10 μl of 4× E-PAGE loading dyeBuffer 1 (Invitrogen catalog #EPBUF-01). Ten microliters was loaded ontoInvitrogen's E-PAGE 96-well gel (catalog #EP096-06), and the gel was runfor 14 minutes. For the Western blot, the proteins were transferred toPVDF membrane using semi-dry blotting apparatus for 1.5 hours at 0.8mA/cm². The primary antibody used for the Western blot was a 1:5000dilution of α-RGP1 antibody from pea. The secondary antibody was goatα-rabbit IgG (H+L)-HRP conjugated (BioRad #170-6515). The blot wasdeveloped using Amersham Biosciences ECL Western blotting detectionreagents kit (RPN2106). Results of the Western blots and control Ponceaustaining of the same blots are shown in FIG. 3.

Based on the results of the Western blots, events were screened fortransformants. The results of the first screen are shown in Table 1.

TABLE 1 Event Knockdown WT:T Ratio 1 fair/weak 4:4 2 fair 3:5 3 fair 2:64 fair 4:4 5 strong 2:6 6 fair/weak 4:4 7 strong 3:5 8 fair/strong 4:4 9strong 5:3 10 fair/strong 4:4 11 fair/strong 4:4 12 fair 4:4 13 fair 4:414 strong 5:3 15 strong 5:3Sample Preparation for Analysis of Hemicellulose Sugars

The remaining ½ embryo or ½ endosperm was pooled into wild-type ortransgenic for each event based on the Western blot results. The pooledendosperm or embryo was ground in the Gendogrinder into a powder. Fiftymilligram samples were weighed out for hemicellulose analysis. Solublesugars were removed by adding 1 ml 80% ethanol and a small stir bar toeach 50-mg sample of ground tissue. The samples were vortexed and heatedat 100° C. for one minute. Samples were centrifuged at 14,000 rpm for 10minutes and the supernatant was discarded. To the pellet, 1 ml ofacetone was added, and the samples were vortexed and centrifuged at14,000 rpm for 10 minutes. The supernatant was discarded and the pelletswere dried. The pellets were de-starched by adding 0.3 ml α-amylasesolution (300 units/assay α-amylase in 50 mM MOPS (pH 7.0), 5 mM calciumchloride, 0.02% sodium-azide) and heated at 90-95° C. for 10 minuteswith constant stirring using a magnetic stir plate. Then 0.2 mlamyloglucosidase (Boehringer Manheim from Aspergillus niger catalog#1202367) solution (20 U/assay amyloglucosidase in 285 mM Sodium-acetatepH 4.5 0.02% Sodium-azide) was added to each tube and incubated at 55°C. overnight. Absolute ethanol was added to each tube to a finalconcentration of 70%, the samples were vortexed and centrifuged at14,000 rpm for 10 minutes. The pellet was washed two times with 1 ml 80%ethanol discarding the supernatant each time. The pellet was washed with1 ml acetone and left to dry. To hydrolyze the hemicellulose sugars, 1ml of 1 M sulfuric acid was added, and the samples were heated at 100°C. for 30 minutes. The samples were cooled on ice and spun at 14,000 rpmfor 10 minutes. The resulting supernatant was used for hemicellulosesugar analysis.

The average control weight of transformed kernel was tabulated (seeTable 2) and the sugar content assayed.

TABLE 2 Average WT Average T % Control Event WT:T Ratio Kernel wt. (mg)Kernel wt. (mg) Avg. wt. 1 9:9 160.02 149.94 93.70 3  8:10 350.72 346.8298.89 4  7:11 236.89 234.76 99.10 5 13:5  311.38 312.46 100.35 7 9:9284.33 244.79 86.09 8  5:13 293.37 266.27 90.76 9  6:12 266.45 258.1496.88 10  10:8  290.57 284.67 97.97 11   7:11 295.63 301.14 101.86 12  3:13 253.72 273.88 107.95 13  6:9 278.83 278.81 99.99 14   4:13 273.75249.15 91.01 15  12:2  320.81 331.36 103.29 Total 278.19 271.70 97.67Analysis of High Performance Anion Exchange Chromatography with PulsedAmperometric Detection (HPAEC_PAD)

HPAEC was used for separation, identification, and quantitation ofarabinose, galactose, glucose, xylose, and mannose. A Dionex DX500 highperformance liquid chromatograph (HPLC) equipped with a GP40 or GP50pump, ED40 electrochemical detector, pulsed amperometric detector (PAD),and AS3500 autosampler was used. Samples were submitted as extracts andfiltered through 0.2 μm spin filters and then quantitatively transferredto 1.8 mL glass vials and diluted with water to a concentration thatallows quantification from a standard curve. Samples were keptrefrigerated at 4° C. Ten-microliter injections were introduced to aDionex CarboPac PA1 guard (4×50 mm) and analytical column (4×250 mm). Anauxiliary pump delivered 300 mM sodium hydroxide through a T-junctureimmediately post column but before the PAD at a constant flow rate of˜0.2 mL/minute. A six-point standard curve with a range from 0.5 μg/mLto 100 μg/mL was used for quantitation. Initial eluent conditions forsugar separation consist of 100% water at a flow rate of 1 mL/minute.Sugars eluted in the order of arabinose, galactose, glucose, xylose, andmannose at approximately 9, 10.5, 13, 16, and 18 minutes respectively.At 20 minutes, a step gradient consisting of 30%-water, 50%-600 mM NaOH,and 20%-300 mM NaOH/500 mM NaOAC, was used to rid the column ofcontaminants. At 32 minutes, a step gradient was used to return to 100%water conditions and re-equilibrate the column to initial conditions.Total run time was 43 minutes.

The results of the sugar content assays are shown in FIGS. 4 through 13.The cumulative results demonstrate that interference with RGP1 using asuppression cassette expressing hpRNA targeting expression of RGP1decreases arabinose concentration in the seed, but not xyloseconcentration in the seed.

Example 2 Maize Transformation

Immature maize embryos from greenhouse donor plants are bombarded with aplasmid containing the suppression cassette and the selectable markergene PAT (Wohlleben et al. (1988) Gene 70:25-37), which confersresistance to the herbicide Bialaphos. Alternatively, the selectablemarker gene is provided on a separate plasmid. Transformation isperformed as follows.

The ears are husked and surface sterilized in 30% Clorox bleach plus0.5% Micro detergent for 20 minutes, and rinsed two times with sterilewater. The immature embryos are excised and placed embryo axis side down(scutellum side up), 25 embryos per plate, on 560Y medium for 4 hoursand then aligned within the 2.5 cm target zone in preparation forbombardment.

A plasmid vector comprising the suppression cassette described above andthe selectable marker gene PAT is made. This plasmid DNA plus plasmidDNA containing a PAT selectable marker is precipitated onto 1.1 μm(average diameter) tungsten pellets using a CaCl₂ precipitationprocedure as follows: 100 μl prepared tungsten particles in water; 10 μl(1 μg) DNA in Tris EDTA buffer (1 μg total DNA); 100 μl 2.5 M CaCl₂;and, 10 μl 10.1 M spermidine.

Each reagent is added sequentially to the tungsten particle suspension,while maintained on the multitube vortexer. The final mixture issonicated briefly and allowed to incubate under constant vortexing for10 minutes. After the precipitation period, the tubes are centrifugedbriefly, liquid removed, washed with 500 ml 100% ethanol, andcentrifuged for 30 seconds. Again the liquid is removed, and 105 μl 100%ethanol is added to the final tungsten particle pellet. For particle gunbombardment, the tungsten/DNA particles are briefly sonicated and 10 μlspotted onto the center of each macrocarrier and allowed to dry about 2minutes before bombardment.

The sample plates are bombarded at level #4 in particle gun #HE34-1 or#HE34-2. All samples receive a single shot at 650 PSI, with a total often aliquots taken from each tube of prepared particles/DNA.

Following bombardment, the embryos are kept on 560Y medium for 2 days,then transferred to 560R selection medium containing 3 mg/literBialaphos, and subcultured every 2 weeks. After approximately 10 weeksof selection, selection-resistant callus clones are transferred to 288Jmedium to initiate plant regeneration. Following somatic embryomaturation (2-4 weeks), well-developed somatic embryos are transferredto medium for germination and transferred to the lighted culture room.Approximately 7-10 days later, developing plantlets are transferred to272V hormone-free medium in tubes for 7-10 days until plantlets are wellestablished. Plants are then transferred to inserts in flats (equivalentto 2.5″ pot) containing potting soil and grown for 1 week in a growthchamber, subsequently grown an additional 1-2 weeks in the greenhouse,then transferred to classic 600 pots (1.6 gallon) and grown to maturity.Mature kernels are collected and scored for expression of the desiredphenotypic trait.

Bombardment medium (560Y) comprises 4.0 g/l N6 basal salts (SIGMAC-1416), 1.0 ml/l Eriksson's Vitamin Mix (1000× SIGMA-1511), 0.5 mg/lthiamine HCl, 120.0 g/l sucrose, 1.0 mg/1 2,4-D, and 2.88 g/l L-proline(brought to volume with D-I H₂O following adjustment to pH 5.8 withKOH); 2.0 g/l Gelrite (added after bringing to volume with D-I H₂O); and8.5 mg/l silver nitrate (added after sterilizing the medium and coolingto room temperature). Selection medium (560R) comprises 4.0 g/l N6 basalsalts (SIGMA C-1416), 1.0 ml/l Eriksson's Vitamin Mix (1000×SIGMA-1511), 0.5 mg/l thiamine HCl, 30.0 g/l sucrose, and 2.0 mg/l 2,4-D(brought to volume with D-I H₂O following adjustment to pH 5.8 withKOH); 3.0 g/l Gelrite (added after bringing to volume with D-I H₂O); and0.85 mg/l silver nitrate and 3.0 mg/l bialaphos (both added aftersterilizing the medium and cooling to room temperature).

Plant regeneration medium (288J) comprises 4.3 g/l MS salts (GIBCO11117-074), 5.0 ml/l MS vitamins stock solution (0.100 g nicotinic acid,0.02 g/l thiamine HCL, 0.10 g/l pyridoxine HCL, and 0.40 g/l glycinebrought to volume with polished D-I H₂O) (Murashige and Skoog (1962)Physiol. Plant. 15:473), 100 mg/l myo-inositol, 0.5 mg/l zeatin, 60 g/lsucrose, and 1.0 ml/l of 0.1 mM abscisic acid (brought to volume withpolished D-I H₂O after adjusting to pH 5.6); 3.0 g/l Gelrite (addedafter bringing to volume with D-I H₂O); and 1.0 mg/l indoleacetic acidand 3.0 mg/l bialaphos (added after sterilizing the medium and coolingto 60° C.). Hormone-free medium (272V) comprises 4.3 g/l MS salts (GIBCO11117-074), 5.0 ml/l MS vitamins stock solution (0.100 g/l nicotinicacid, 0.02 g/l thiamine HCL, 0.10 g/l pyridoxine HCL, and 0.40 g/lglycine brought to volume with polished D-I H₂O), 0.1 g/1 myo-inositol,and 40.0 g/l sucrose (brought to volume with polished D-I H₂O afteradjusting pH to 5.6); and 6 g/l bacto-agar (added after bringing tovolume with polished D-I H₂O), sterilized and cooled to 60° C.

Example 3 Agrobacterium-Mediated Transformation

For Agrobacterium-mediated transformation of maize with the suppressioncassette, the method of Zhao is employed (U.S. Pat. No. 5,981,840, andPCT patent publication WO98/32326; the contents of which are herebyincorporated by reference). Briefly, immature embryos are isolated frommaize and the embryos contacted with a suspension of Agrobacterium,where the bacteria are capable of transferring the suppression cassetteof the invention to at least one cell of at least one of the immatureembryos (step 1: the infection step). In this step the immature embryosare immersed in an Agrobacterium suspension for the initiation ofinoculation. The embryos are co-cultured for a time with theAgrobacterium (step 2: the co-cultivation step). The immature embryosare cultured on solid medium following the infection step. Followingthis co-cultivation period an optional “resting” step is contemplated.In this resting step, the embryos are incubated in the presence of atleast one antibiotic known to inhibit the growth of Agrobacteriumwithout the addition of a selective agent for plant transformants (step3: resting step). The immature embryos are cultured on solid medium withantibiotic, but without a selecting agent, for elimination ofAgrobacterium and for a resting phase for the infected cells. Next,inoculated embryos are cultured on medium containing a selective agentand growing transformed callus is recovered (step 4: the selectionstep). The immature embryos are cultured on solid medium with aselective agent resulting in the selective growth of transformed cells.The callus is then regenerated into plants (step 5: the regenerationstep), and calli grown on selective medium are cultured on solid mediumto regenerate the plants.

Example 4 Soybean Embryo Transformation

Soybean embryos are bombarded with a plasmid containing the suppressioncassette of the invention as follows. To induce somatic embryos,cotyledons, 3-5 mm in length dissected from surface-sterilized, immatureseeds of the soybean cultivar A2872, are cultured in the light or darkat 26° C. on an appropriate agar medium for six to ten weeks. Somaticembryos producing secondary embryos are then excised and placed into asuitable liquid medium. After repeated selection for clusters of somaticembryos that multiplied as early, globular-staged embryos, thesuspensions are maintained as described below.

Soybean embryogenic suspension cultures can be maintained in 35 mlliquid media on a rotary shaker, 150 rpm, at 26° C. with florescentlights on a 16:8 hour day/night schedule. Cultures are subcultured everytwo weeks by inoculating approximately 35 mg of tissue into 35 ml ofliquid medium.

Soybean embryogenic suspension cultures may then be transformed by themethod of particle gun bombardment (Klein et al. (1987) Nature (London)327:70-73, U.S. Pat. No. 4,945,050). A Du Pont Biolistic PDS1000/HEinstrument (helium retrofit) can be used for these transformations.

A selectable marker gene that can be used to facilitate soybeantransformation is a transgene composed of the 35S promoter fromCauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812), thehygromycin phosphotransferase gene from plasmid pJR225 (from E. coli;Gritz et al. (1983) Gene 25:179-188), and the 3′ region of the nopalinesynthase gene from the T-DNA of the Ti plasmid of Agrobacteriumtumefaciens. The expression cassette comprising the suppression cassetteof the invention can be isolated as a restriction fragment. Thisfragment can then be inserted into a unique restriction site of thevector carrying the marker gene.

To 50 μl of a 60 mg/ml 1 μm gold particle suspension is added (inorder): 5 μl DNA (1 μg/μl), 20 μl spermidine (0.1 M), and 50 μl CaCl₂(2.5 M). The particle preparation is then agitated for three minutes,spun in a micro fuge for 10 seconds and the supernatant removed. TheDNA-coated particles are then washed once in 400 μl 70% ethanol andresuspended in 40 μl of anhydrous ethanol. The DNA/particle suspensioncan be sonicated three times for one second each. Five microliters ofthe DNA-coated gold particles are then loaded on each macro carrierdisk.

Approximately 300-400 mg of a two-week-old suspension culture is placedin an empty 60×15 mm petri dish and the residual liquid removed from thetissue with a pipette. For each transformation experiment, approximately5-10 plates of tissue are normally bombarded. Membrane rupture pressureis set at 1100 psi, and the chamber is evacuated to a vacuum of 28inches mercury. The tissue is placed approximately 3.5 inches away fromthe retaining screen and bombarded three times. Following bombardment,the tissue can be divided in half and placed back into liquid andcultured as described above.

Five to seven days post bombardment, the liquid media may be exchangedwith fresh media, and eleven to twelve days post-bombardment with freshmedia containing 50 mg/ml hygromycin. This selective media can berefreshed weekly. Seven to eight weeks post-bombardment, green,transformed tissue may be observed growing from untransformed, necroticembryogenic clusters. Isolated green tissue is removed and inoculatedinto individual flasks to generate new, clonally propagated, transformedembryogenic suspension cultures. Each new line may be treated as anindependent transformation event. These suspensions can then besubcultured and maintained as clusters of immature embryos orregenerated into whole plants by maturation and germination ofindividual somatic embryos.

Example 5 Expression Profile of the Gbl2 Promoter

The most abundant proteins present in maize (Zea mays L.) embryos aresaline soluble globulins. A Mr 45,000 globulin component, designatedGlb2, is encoded by the Glb2 gene. A cDNA clone corresponding to Glb2was used as a radiolabeled probe to examine the expression of Glb2 indeveloping embryos and other maize tissues. Glb2 transcripts accumulateduring embryo development and are not detectable in germinating kernels.Glb2 transcripts are found only in the developing embryo, and not inendosperm, seedling, or unfertilized ears.

LYNX Data demonstrated that the GLB2 transcript is detected in very fewlibraries. It appears to come on between 20-24 DAP and off by 35 DAP.GLB2 has virtually no signal from the aleurone which makes it veryunique in the class of embryo promoters. See, FIG. 14.

RT-PCR was also performed to determine the expression pattern of theGlb2 promoter. The GLB2 transcript is detected in whole kernel samplesfrom 26-40 DAP. No signal was detected in vegetative samples. Data notshown.

And finally, Kernels were screened at 5 DAP intervals beginning at 10DAP. Expression was observed first at 20 DAP. No expression was observedin leaf or pollen. Data not shown.

All publications and patent applications mentioned in the specificationare indicative of the level of those skilled in the art to which thisinvention pertains. All publications and patent applications are hereinincorporated by reference to the same extent as if each individualpublication or patent application was specifically and individuallyindicated to be incorporated by reference.

Although the foregoing invention has been described in some detail byway of illustration and example for purposes of clarity ofunderstanding, it will be obvious that certain changes and modificationsmay be practiced within the scope of the appended claims.

That which is claimed:
 1. A method for decreasing the expression levelof at least one polynucleotide of interest in a plant or part thereof,said method comprising a) introducing into a cell of said plant a DNAsuppression cassette comprising a silencing element flanked by a firstoperably linked convergent seed-preferred promoter at one terminus ofthe silencing element and a second operably linked convergentseed-preferred promoter at the opposing terminus of the silencingelement, wherein the first and the second convergent promoters arecapable of driving expression of the silencing element wherein the firstand the second convergent promoters have a different expression profile,said silencing element is transcribed as a hairpin RNA and expression ofsaid silencing element decreases the expression level of reversiblyglycosylated polypeptide-1 (RGP1); wherein said silencing elementcomprises, in the following order, a first segment, a second segment,and a third segment, wherein i) said first segment comprises at leastabout 20 nucleotides of SEQ ID NO:2 and said first fragment comprisingat least 90% sequence complementary to a target polynucleotide encodingRGP1; ii) said second segment comprises a loop of sufficient length toallow the silencing element to be transcribed as a hairpin RNA; and,iii) said third segment comprises at least about 20 nucleotides havingat least 85% complementary to the first segment; and, b) expressing saidsilencing element from both the first and the second convergentpromoters, and thereby decreasing the level of expression of the targetpolynucleotide encoding RGP1.
 2. The method of claim 1, wherein saidfirst and said second convergent promoters are selected from the groupconsisting of an embryo-preferred promoter, an aleurone-preferredpromoter, a pericarp-preferred promoter, and an endosperm-preferredpromoter.
 3. The method of claim 2, wherein said first convergentpromoter is the endosperm-preferred promoter and said second convergentpromoter is the embryo-preferred promoter.
 4. The method of claim 3,wherein said first convergent promoter is a gamma-zein promoter and saidsecond convergent promoter is an oleosin promoter.
 5. The method ofclaim 3, wherein at least one of said first or second convergentpromoters is selected from the group consisting of a 27 kDa zeinpromoter, a oleosin promoter, a maize L3 oleosin promoter, or a maizeglobulin 1 promoter.
 6. The method of claim 1, wherein said plant is amonocot.
 7. The method of claim 1, wherein said plant is a dicot.
 8. Themethod of claim 1, wherein said plant is selected from the groupconsisting of corn, oat, soybean, wheat, rice, canola, Brassica sp.,sorghum, sunflower, barley, millet, cotton, peanut, flax, safflower,palm, olive, castor bean, and coconut.
 9. The method of claim 1, whereinthe level of expression of the target polynucleotide encoding RGP1 isdecreased in a part of the seed.
 10. The method of claim 9, wherein saidseed part is an endosperm of a seed.
 11. The method of claim 9, whereinsaid seed part is an embryo of a seed.
 12. A DNA suppression cassettecomprising a silencing element flanked by a first operably linkedconvergent seed-preferred promoter at one terminus of the silencingelement and a second operably linked convergent seed-preferred promoterat the opposing terminus of the silencing element, wherein the first andthe second convergent promoters are capable of driving expression of thesilencing element wherein the first and the second corvergent promotershave a different expression profile, said silencing element istranscribed as a hairpin RNA, and expression of said silencing elementdecreases the expression level of reversibly glycosylated polypeptide-1(RGP1); wherein said silencing element comprises, in the followingorder, a first segment, a second segment, and a third segment, whereina) said first segment comprises at least about 20 nucleotides of SEQ IDNO:2 and said first fragment comprising at least 90% sequencecomplementary to a target polynucleotide encoding RGP1; b) said secondsegment comprises a loop of sufficient length to allow the silencingelement to be transcribed as a hairpin RNA; and, c) said third segmentcomprises at least about 20 nucleotides having at least 85%complementary to the first segment.
 13. The DNA suppression cassette ofclaim 12, wherein said first and said second convergent promoters areactive in a plant cell.
 14. The DNA suppression cassette of claim 12,wherein said first and said second convergent promoters are selectedfrom the group consisting of an embryo-preferred promoter, analeurone-preferred promoter, a pericarp-preferred promoter, and anendosperm-preferred promoter.
 15. The DNA suppression cassette of claim14, wherein said first convergent promoter is an endosperm-preferredpromoter and said second convergent promoter is an embryo-preferredpromoter.
 16. The DNA suppression cassette of claim 15, wherein saidfirst convergent promoter is a gamma-zein promoter and said secondconvergent promoter is an oleosin promoter.
 17. The DNA suppressioncassette of claim 16, wherein said silencing element comprises thenucleotide sequence set forth in SEQ ID NO:2.
 18. A vector comprisingthe DNA suppression cassette of claim
 12. 19. A plant comprising the DNAsuppression cassette of claim
 13. 20. The plant of claim 19, whereinsaid plant is a monocot.
 21. The plant of claim 19, wherein said plantis a dicot.
 22. The plant of claim 19, wherein said plant is selectedfrom the group consisting of corn, oat, soybean, wheat, rice, canola,Brassica sp., sorghum, sunflower, barley, millet, cotton, peanut, flax,safflower, palm, olive, castor bean, and coconut.
 23. The plant of claim20, wherein said monocot is selected from the group consisting of maize,wheat, rice, barley, sorghum, or rye.
 24. The plant of claim 21, whereinsaid dicot is selected from the group consisting of soybean, canola,sunflower, cotton, or alfalfa.
 25. A transgenic seed from the plant ofclaim
 19. 26. A plant cell comprising the DNA suppression cassette ofclaim
 13. 27. The plant cell of claim 26, wherein said plant is amonocot.
 28. The plant cell of claim 26, wherein said plant is a dicot.29. The plant cell of claim 27, wherein said monocot is selected fromthe group consisting of maize, wheat, rice, barley, sorghum, or rye. 30.The plant cell of claim 28, wherein said dicot is selected from thegroup consisting of soybean, canola, sunflower, cotton, or alfalfa.